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1 General Abstract 
Vascularization is still a great challenge in Tissue Engineering. First this is 
important to avoid mass transfer limitation in engineered tissues but also for 
innovative in vivo and in vitro applications. A pre-vascularized tissue can 
accelerate the formation of functional anastomosis with host vasculature in vivo 
ensuring the sustenance of the implant, its integration and long term survival. In the 
same time, in vitro, it can be a suitable model in view of fundamental research 
about physiological and pathological angiogenesis and industrial applications like 
drugs screening. 
In this work, we analyse the formation of capillary like networks into pathological 
and physiological tissues obtained by bottom up approach and strengthened by an 
endogenous extracellular matrix (ECM).  
The introduction describes the fundamental role of vascularization in tissue 
engineering and the bottom up approach that we exploit in order to obtain stroma-
rich tissues. Chapter 2 retraces interesting steps of the state of art regarding 3D 
engineered models of pathological and physiological conditions, specifically, 
analyzing human breast and skin tissues and underling the role of 
microenvironment in tissue functionality. Chapter 3 and 4 are dedicated to the 
description of our work with the aim to achieve and investigate the features of 
vascularized pathological and physiological engineered models suitable for 
pharmaceutical and clinical applications. 
Notably, chapter 3 describes the development of vascularized breast cancer micro-
tissues which are able to recapitulate tumor vascular pro-angiogenic and stromal 
desmoplastic reaction, and heterogeneity in cluster migration during interstitial 
invasion.  
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On the other hand, chapter 4 shows how healthy micro-tissues are assembled and 
cultured in order to obtain vascularized dermis/skin equivalents mirroring 
physiological angiogenesis. 
Both models are featured by the presence of an active and organized stroma which 
is part of an interactive microenvironment and able to receive, store and release 
physio-pathological stimuli. 
We speculate that the vascularized dermis/skin model could be useful for in vivo 
applications in order to repair and restore damaged tissues. Furthermore, both 
vascularized tumor and healthy tissues are suitable research models. Thus, allowing 
the study of tumor progression, physio-pathological angiogenesis and providing a 
platform for drug screening on multicomponent systems. 
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1.1 General Introduction 
1.1.1 The fundamental role of vascularization and ECM in Tissue 
Engineering and main strategies 
Tissue microenvironment consists of a dynamic population of cellular and non-
cellular components which form a multifaceted regulatory network that helps to 
maintain tissue homeostasis. Fundamental elements of the microenvironment are 
the vascular network and the extracellular matrix (ECM) which features regulate 
tissue functionality. These normal cellular and non-cellular microenvironment 
components are not only essential for tissue normal, physiological and biological 
behavior, but are critical in opposing resistance to malignant cell growth [24].  
Mimic vascularization is still a great challenge in Tissue Engineering. First this is 
important to avoid mass transfer limitation in engineered tissues but also for 
innovative in vivo and in vitro applications [1]. Most cells of human body are found 
no more than 100–200 µm from the nearest capillary, with this spacing providing 
sufficient diffusion of oxygen, nutrients, and waste products to support and 
maintain viable tissue [2]. Similarly, every reconstructed tissue or organ that 
exceeds 400 μm in any dimension must be vascularized in order to survive and to 
be able to fulfill their biological functions. This need for vascularization exists both 
at the stage when tissue-engineered constructs are grown and/or assembled in vitro 
and when they are implanted in patients [1].  
A pre-vascularized tissue has a high potential for in vivo applications as it provides 
functional points of anastomosis with the host vascular system present in the 
implant site [2], promotes tissue functionalization and innervation because 
endothelial cells (ECs) are able to retrieve neural precursors through the release of 
neurotrophic factors [3]. In research a pre-vascularized tissue is a model to study 
angiogenesis, wound healing or vascular phenomena such as thrombosis or 
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metastatic events involving tumor-endothelial cells interaction. In view of 
industrial applications vascularized constructs represent a platform to study drugs 
or active principles such as anti-inflammatory, pro- and anti-angiogenic, vaso-
constrictors/dilators [1]. In some recent works, it is emphasized the importance of 
the lymphatic vascular system, in addition to the blood one, for the maintenance of 
fluids homeostasis and for the transport of cells of the immune system [4]. 
The two processes through which neovascularization can take place in tissues are 
angiogenesis and vasculogenesis. Angiogenesis is the process through which new 
blood vessels are formed from preexisting ones, whereas vasculogenesis generates 
new vascularization in the absence of preexisting blood vessels. For the most part, 
normal vasculogenic formation of new capillaries takes place during embryologic 
development, although in some instances, such as wound healing and the menstrual 
cycle, neovascularization can be seen in adults. Pathological angiogenesis occurs in 
some disease states such as tumor growth or chronic inflammatory diseases [1]. 
Two distinct mechanisms of angiogenesis have been described: sprouting and 
intussusception. Intussusceptive angiogenesis is caused by the insertion of 
interstitial cellular columns into the lumen of preexisting vessels. The subsequent 
growth of these columns and their stabilization results in partitioning of the vessel 
and remodeling of the local vascular network. Sprouting angiogenesis entails two 
successive phases: neovessel growth and neovessel stabilization. During the initial 
phase, the following sequence of events usually occurs: dissolution of the basement 
membrane of the “mother” vessel and its surrounding interstitial matrix, migration 
of endothelial cells in this created space toward the angiogenic factor, proliferation 
of endothelial cells behind the front of migration, lumen formation within the 
endothelial sprout, and formation of loops by anastomoses of sprouts. The 
stabilization phase consists of arrest of endothelial cell proliferation, reconstruction 
of a basement membrane around the neocapillary, and investment and coverage of 
the immature capillary with pericytes.[5]. 
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Vascular networks formed by vessel sprouting undergo extensive vascular 
remodeling to form a functional and mature vasculature. This ‘‘trimming’’ includes 
distinct processes of vascular pruning, the regression of selected vascular branches. 
In some situations complete vascular networks may undergo physiological 
regression. Vessel regression is an understudied yet emerging field of research. For 
example this happens during the regression of hyaloid vessels and in the adult 
during luteolysis (Fig.1). Luteolysis marks the rapid dissociation of the mature 
ovarian corpus luteum at the end of the ovarian cycle. Triggered by the 
downregulation of VEGF and the upregulation of ANG2, the extensive vascular 
network of the corpus luteum completely dissociates within a few days and 
gradually resolves into scar tissue over a period of weeks. This prominent example 
illustrates that nature has secured mechanisms and pathways for the controlled 
dissociation of established vascular networks. It also highlights that vessel 
regression may be triggered by the shut-off of ON signals (e.g., VEGF) as well as 
the active engagement of OFF signals (e.g., ANG2). [6]. 
 
Fig.1 Concepts of Angiogenesis and Vessel Regression as Dynamic Processes. Mature vascular networks 
may undergo complete vascular regression. In the ovary, growth and regression of the cyclic corpus 
luteum is associated with distinct phases of angiogenesis, vessel maturation, and vessel regression. 
Luteolysis leads to the physiologically triggered massive destruction of the entire corpus luteum 
vasculature [6]. 
Angiogenesis events are finely regulated at the molecular level by the expression of 
pro- and anti-angiogenic factors (Tab.1) [7]. 
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There are several vascularization strategies in Tissue Engineering, some aim to 
promote host vessels invasion into the construct directly after in vivo implantation 
and others to the development of pre-vascularized tissues [2]. The main strategy of 
Tissue Engineering involves the use of cells, scaffolds and growth factors [8]. The 
scaffold is a structural support able to guide the reorganization and cell growth. It 
can be functionalized using pro-angiogenic growth factors such as VEGF (Vascular 
Endothelial Growth Factor), PDGF (Platelet-derived Growth Factor) and heparin. 
Despite the functionalization methods are very effective, the use of these scaffolds 
is limited by the difficulty to adjust the kinetics release of various pro-angiogenic 
factors over time in vivo. The scaffolds can also be functionalized physically 
increasing the porosity or with the presence of channels in the structure [2]. 
Table 1 List of proangiogenic and antiangiogenic factors. Adapted from [7] 
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In many works the vascularization strategy is based on the co-culture of endothelial 
cells with other cell types. In fact when endothelial cells are cultured in vitro under 
permissive conditions, in particular when they are in 3 dimensional (3D) co-culture 
with other cell types and a relevant ECM, they are able to spontaneously form 
capillary networks [1]. Auger et al in 2006 have shown that fibroblasts promote 
endothelial cells proliferation, migration and angiogenesis. This is due to their 
ability to produce an organized ECM and growth factors that represent a suitable 
microenvironment to promote the organization of endothelial cells in 3D and the 
formation of capillary-like tubular structures [9]. Cells can be seeded into 3D 
hydrogel or natural/synthetic scaffolds able to provide a biocompatible support 
miming the role of the ECM [10]. 
As native tissues are finely organized, modulating scaffold micro-architecture can 
be a powerful way to get biomimetic tissues [11]. This type of functionalization 
often exploits a physical guidance (e.g. holes or channels) or chemistry to create 
cell patterns [12]. Tien et al in 2006 have described the construction of 
microvascular tubes of endothelial cells with final diameters ranging from 75 to 
150 μm into Rat Tail Type I collagen. The endothelial cells tubes slightly increase 
in diameter after maturation, show a strong barrier function, resistance to leukocyte 
adhesion in normal condition and a quick responsiveness to inflammatory stimuli 
leading the increase in vascular permeability and leukocytes adhesion [13]. 
Bertassoni et al developed a channel network into hydrogel at different 
concentration using agarose fibers with a 3D defined architecture as mold. 
Channels can have different diameters, are totally covered by endothelial cells and 
perusable [14].  
Using the 3D bio-printing technology, Lee et al have obtained functional and 
perfused vascular channels within a collagen scaffold. The channels have a lumen 
and the inner surface is covered by a confluent monolayer of endothelial cells. The 
perfused channel supports the vitality of the adjacent tissue and shows a barrier 
19 
 
function for the BSA (Bovine Serum Albumin) and dextran. The vascular channel 
maintains its integrity in long-term cultures in flow condition and the endothelial 
cells are aligned in the direction of flow. In static conditions, endothelial cells are 
able to proliferate and sprout, forming structures that branch off from the channel 
towards the outside and have a lumen. On the other hand, during flow condition 
endothelial cells proliferation is suppressed and the cells remain confined within 
the channel structure [15]. 
The geometric control of the vascular network is important for engineered tissues 
functionalization as well as for their in vivo integration [16]. Chen et al obtained 
cords of endothelial and mesenchymal cells in type I collagen within micro-
channels in PDMS (polydimethylsiloxane). These cords were coated with fibrin 
from one side, detached from PDMS and then covered with fibrin on the other side. 
The obtained construct was sutured directly into the parametrial fat pad in the 
intraperitoneal space of nude mice. Analysis conducted at various days after 
implantation allowed detecting that endothelial cells cords perfectly anastomosed 
with host vessels and were perfused by blood. They showed that geometrically 
controlled constructs survive more effectively and were more functional than 
random ones [16]. 
Besides vascularization, the other fundamental micro-environmental component to 
mimic in engineered tissue is the ECM. It is a heterogeneous, connective network 
composed of fibrous glycoproteins that coordinate in vivo to provide the physical 
scaffolding, mechanical stability, and biochemical cues necessary for tissue 
morphogenesis and homeostasis [17]. 
In the classical tissue engineering approach, or top-down approach, cells are seeded 
into preformed, functionalized, porous, and biodegradable polymeric scaffolds 
acting as temporary template for new tissue growth and reorganization, replacing 
ECM functions. One of the limits of this traditional method is that it difficulty 
recreate the intricate microstructural features of 3D-tissue. For this reason, efforts 
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have been devoted to bottom-up approaches aimed at generating a larger tissue 
construct by assembling smaller building blocks that mimic the in vivo tissue 
structure of repeating functional units. These building blocks can be created in 
several ways, such as self-assembled cell aggregates, microfabrication of cell-laden 
microgel, creation of cell sheets, and microfabrication of cell seeded microbeads. 
Once obtained, these building blocks can be assembled in larger tissue through a 
number of methods including random packing, stacking of layers, or direct 
assembly [18]. By mimicking native microstructural functional units, bottom-up 
approaches aim to create more biomimetic engineered tissues. One of the major 
challenges by using this approach is to assemble modular tissues with specific 
micro architectures into macroscale biomimetic engineered tissues with robust 
mechanical properties [19][20]. 
To address this issue, we use a bottom-up method to fabricate micron-sized tissue 
of connective origin by coupling cells and micro-scaffold. Despite other bottom-up 
strategies are completely scaffold-free, we use a porous micron-sized scaffold as a 
temporary support that plays a crucial role in guiding the correct spatial 
organization of the de novo synthesized ECM. This way, the micro-tissue is more 
than a mere cell aggregate: it represents a more complex living structure in which 
the cell works as tissue builder. These micro-tissues are then used as building 
blocks to create 3D functional tissues [18]. 
In this work, we exploit dynamic cell seeding on porous gelatin micro-carriers 
using a spinner flask bioreactor. We use human fibroblasts extracted from the 
dermis and gelatin porous µspheres, crosslinked by 4% w/w glyceraldehyde, as 
scaffold. During the dynamic culture, cells adhere, proliferate and synthesize a thin 
layer of ECM in and around the beads, generating µTPs rich in type I collagen. The 
cells and ECM layer around the µTPs allow their biological sintering via cell–cell 
and cell–matrix interaction after only a few days of dynamic seeding. The 
assembling ability of µTPs is exploited by placing them into specific maturation 
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chamber, in order to obtain final macro-tissues. They have tunable shape and 
dimensions, depending on the shape of the mold used into the maturation chamber, 
are scaffold free after the maturation period of about 4 weeks and are enriched by a 
strong collagen rich matrix [21] [22] [23]. It was demonstrated that modulating the 
crosslinking density of the gelatin micro-scaffolds it is possible to guide the 
process of collagen deposition and assembly within the extracellular space and 
match the processes of scaffold degradation, cell traction and tissue maturation to 
obtain firmer collagen network able to withstand the effect of contraction. We use 
4% w/w glyceraldehyde to obtain a massive deposition of immature collagen that is 
progressively assembled in mature collagen fibrils. The relationship between the 
degradation time of the scaffold and the synthesis of collagen is just below the unit 
by determining an intermediate tissue ability to resist contraction [24]. 
This process has been used to develop both 3D dermal equivalent and cardiac-
muscle fabrication [18]. 
Human keratinocytes seeded on this dermis equivalent model are able to develop a 
mature and functional epithelium. In such physiologically relevant environment our 
group observed the development of appendage-like structures, which resemble the 
structure of the first step of hair follicle embryogenesis, without adding 
mesenchymal stem cells. Such results suggest a possible regulatory role of the 
dermis in the skin equivalent model, highlighting that it represents an instructive 
environment in which the inductive signals and the ability to maintain the 
germinative phenotypes of the basal keratinocytes can be preserved [22] 
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2 State of the art 
Here we describe the state of the art relative to stroma-rich tissues, namely breast 
and skin in pathological and physiological state, respectively. We underline the 
importance of reproducing micro-environmental conditions in order to obtain 
biomimetic 3D engineered tissues useful for in vitro and in vivo applications. 
2.1 Pathological tissue: Breast Cancer 
2.1.1 Breast Cancer: In vivo overview 
Breast cancer is the second most common cancer in the world after lung cancer and 
the most frequent among women [25]. It is a malignant tumor that starts in the cells 
of the breast. It is found mostly in women, but men can get breast cancer, too. A 
woman's breast is made up of glands that can make breast milk (lobules), small 
tubes that carry milk from the lobules to the nipple (ducts), fatty and connective 
tissue, blood vessels, and lymph vessels (Fig.1). 
 
Fig. 1: Design of normal breast  made up of lobules, ducts, fatty and connective tissue, blood vessels, and 
lymph vessels [26]. 
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Most breast cancers begin in the cells that line the ducts. Fewer breast cancers start 
in the cells lining the lobules [26]. Nearly all breast cancers are adenocarcinomas. 
It is a type of carcinoma that starts in gland tissue (that makes and secretes a 
substance). The ducts and lobules of the breast are gland tissues because they make 
breast milk, so cancers starting in these areas are often called adenocarcinomas[26]. 
The mature gland comprises a branching bilayered epithelium of inner luminal cells 
enveloping ducts positive for cytokeratin 18 (K18) and lobulo-alveolar structures 
surrounded by a thin myoepithelium which stain positively for cytokeratin 14 
(K14) and smooth muscle actinin (α-SMA), enveloped within an adipose rich 
stroma (Fig.2). The mammary epithelium is highly dependent upon the 
composition of basement membrane (BM) proteins, specifically laminin species, 
for its apico-basal polarity and function [27]. 
 
Fig. 2: Ultrastructure of the murine mammary gland. (A) Whole-mount and (B) higher power 
micrograph (10-day gestation) and (C) schematic showing a branched epithelium (e) composed of ducts 
(d) and acini (a) within an adipocyte-rich fat pad (fp) with a prominent lymph node (l). Bars = 1 mm and 
50 μm [27]. 
Breast cancer starts as a local disease, but it can metastasize to the lymph nodes and 
distant organs [28]. Once disseminated, metastases from carcinoma of the breast 
are formed in various organs. The common sites for metastatic spread are bone, 
lung and liver [28] (Fig.3). Breast cancers are classified in: 
- Ductal carcinoma in situ (DCIS): generally non-invasive; 
- Invasive (or infiltrating) ductal carcinoma (IDC): the most common breast 
cancer. It starts in the cells lining a duct, and then the abnormal cells break 
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through the wall of the duct and grow into (invade) the tissue of the breast 
and can spread to nearby lymph nodes or other parts of the body; 
- Invasive (infiltrating) lobular carcinoma (ILC): it starts in the cells lining 
the milk glands (the lobules). The cells grow through the wall of the lobules 
and then can spread to nearby lymph nodes or other parts of the body; 
- Inflammatory breast cancer (IBC): a rare type of invasive breast cancer 
[26]. 
 
Fig. 3: Most common metastasis sites of breast cancer. Primary breast cancer cells metastasize through 
the blood vessels to various distant organs, preferentially, to the lung, liver and bones. Patients 
frequently develop metastases at multiple sites [28]. 
At now, the main types of treatment for breast cancer are: surgery, radiation, 
chemotherapy, hormone therapy, targeted therapy or bone-directed therapy.  
Because advanced breast cancers are often hard to treat, researchers are looking for 
newer, better drugs. A drug class has been developed that targets cancers caused by 
BRCA mutations. This class of drugs is called PARP inhibitors and they have 
shown promise in clinical trials treating breast, ovarian, and prostate cancers that 
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had spread and were resistant to other treatments. Further studies are being done to 
see if this drug can help patients without BRCA mutations. 
Targeted therapies are a group of newer drugs that take advantage of gene changes 
in cells that cause cancer. Drugs that target the HER2 protein and anti-angiogenesis 
drugs are being tested in clinical trials [26]. 
Despite significant improvements in research and development in the cancer field, 
about 95% of oncology drugs in clinical trials fail to receive approval. Part of the 
issue is the lack of suitable preclinical models that take into account the complexity 
of the disease and accurately represent disease progression. A growing need exists 
for technologies in research that can recapitulate the in vivo environment [29]. 
Difficulties arise from the evidence that breast cancer is a heterogeneous disease 
[28]. There is a high degree of diversity between and within tumors as well as 
among cancer-bearing individuals, and all of these factors together determine the 
risk of disease progression and therapeutic resistance [30]. Furthermore, patients 
with breast cancer are at risk of experiencing metastasis for their entire lifetime. 
The heterogeneous nature of breast cancer metastasis makes it difficult not only to 
define cure for this disease, but also to assess risk factors for metastasis [28]. 
2.1.2 Cancer microenvironment 
In recent years, it has been shown that breast cancer consists not only of neoplastic 
cells, but also of significant alterations in the surrounding stroma or tumor 
microenvironment. These alterations are now recognized as a critical element for 
breast cancer development and progression, as well as potential therapeutic targets 
[31]. Tumor microenvironment is a complex milieu comprising cancer and non-
cancer cells embedded into the ECM (Fig.4) [32]. Tumors are a heterogeneous 
mixture of epithelial cells consisting of cancer stem cells (CSCs) that have mixed 
epithelial–mesenchymal phenotypes and non-stem cells that are epithelial. Non-
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cancer cells are inflammatory/immune cells, vascular cells and cells of 
mesenchymal origin (e.g. fibroblasts, myofibroblasts, adipocytes or mesenchymal 
stem cells). The ECM can be subdivided into the more compact basement 
membrane — which is a specialized ECM that is rich in type IV collagen, laminin 
and fibronectin — and the interstitial matrix, which consists of fibrillar collagens, 
proteoglycans and glycoproteins [33]. The ECM provides structural support to the 
tissue and acts as a reservoir of growth factor and cytokines [32].  
 
 
Fig. 4: Tumor microenvironment is a complex milieu comprising cancer cells, non-cancer cells as 
inflammatory/immune cells, vascular cells, cells of mesenchymal origin (e.g. fibroblasts, mesenchymal 
cells) and the ECM which provides tissue structural support and acts as reservoir of growth factors and 
cytokines [32][33].  
 Angiogenic switch in cancer  
In order to understand tumor growth, it needs consider components of the stromal 
microenvironment, such as the vasculature.  
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Like normal tissues, tumors require an adequate supply of oxygen, metabolites and 
an effective way to remove waste products. Tissues beyond 1-2mm in diameter 
must recruit new blood vessels by vasculogenesis and angiogenesis to sustain 
growth. Physiologically these processes are regulated by a fine balance between 
pro- and antiangiogenic molecules which is altered in cancer. This process is called 
angiogenic switch and it depends on how heavily that balance tips in favor of pro-
angiogenesis [34]. Pro-angiogenic gene expression is increased by physiological 
stimuli, such as hypoxia, which results from increased tissue mass, and also by 
oncogene activation or tumor-suppressor mutation. Hypoxia and acidosis are the 
most prominent consequences of deregulated vascular function and promote tumor 
progression and new vessel formation by activating a variety of transcriptional 
factors [35]. The angiogenic switch can occur at different stages of the tumor 
progression pathway, depending on tumor type and environment [34]. Without 
blood vessels, tumors cannot grow beyond a critical size or metastasize to another 
organ [36] and enter a dormant though viable state until they are able to secrete 
angiogenic factors and downregulate angiogenic suppressors (Fig.5) [37]. 
The fact that tumors are dependent on blood supply has inspired many researchers 
to search for anti-angiogenic molecules, and to design antiangiogenic strategies for 
cancer treatment [34]. Currently relevant anti-angiogenic agents are used in the 
clinic and target the vascular endothelial growth factor system such as 
bevacizumab, ramucirumab and sorafenib. The efficacy of anti-angiogenic drugs in 
adjuvant therapy or as neo-adjuvant treatment has been estimated in clinical trials 
of advanced breast cancer. To date, the overall observed clinical improvements are 
unconvincing, and further research is required to demonstrate the efficacy of anti-
angiogenic drugs in breast cancer treatments. The outcomes of anti-angiogenic 
therapy have been highly variable in terms of tumor response [38]. This could be 
due to the fact that tumor heterogeneity leads to heterogeneity in the tumor 
vasculature [34]. Furthermore, it’s important consider that without an 
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homogeneous blood supply it become difficult to deliver anti-cancer drugs to all 
regions of a tumor in effective quantities [36].  
 
 
Fig.5: Angiogenic switch:  In dormant tumors there is a balance between angiogenic and anti-angiogenic 
factors. When this equilibrium is destroyed by the prevalence of angiogenic factors, tumor can grow[37]. 
 Tumor vessels characteristics 
Tumor vascular heterogeneity depends from the loss of the appropriate balances 
between positive and negative controls. 
Consequently, the vascular network develops 
unique characteristics and becomes quite 
distinct from the normal blood supply system. 
One feature of tumor blood vessels is that they 
fail to become quiescent, enabling the constant 
growth of new tumor blood vessels.[34]. 
Nevertheless, tumor blood vessels are more 
abundant at the tumor–host interface than in central regions. So, even if there are 
tumor areas richly vascularized, there are also some zones of ischemia and necrosis 
[39].  
Tumor Dormancy Tumor can growth and spread 
Fig. 6Schematic tumor blood vessel [40]. 
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Tumor microvascular architecture has unique abnormal features. Tumor blood 
vessels have thin walls, tortuous shape, absence of pericytes, and variation in 
diameter. Numerous gaps or fenestrae are found between endothelial cells. The 
vessel wall is a mosaic and can consist of both tumor cells as well as endothelial 
cells (Fig.6) [40]. Tumors have an atypical branching pattern, they exhibit 
trifurcations, true and self-loop and polygonal structure of the capillary meshwork 
which cannot be classified by any preexisting branching scheme. (Fig. 7) [41].
 
Fig. 7 Representation of some of tumor vasculature features: A) Trifurcation, presence of self/true loop 
and variation in the diameter. B) Capillary meshwork [41]. 
Because angiogenesis is essential for breast cancer, several groups have tried to 
find quantitative parameters correlated with its progression.  
Young et al found that micro-vessel density correlated significantly with several 
prognostic factors, including lymph node metastasis [42]. 
Some interesting studies have shown that fractal geometry can be useful for 
describing the pathological architecture of tumors and for yielding insight into the 
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mechanism of tumor growth and angiogenesis. This because the fractal dimension 
can quantify the degree of randomness to the vascular distribution, a characteristic 
not easily captured by the vascular density (Fig.8) [43]. 
 
Fig. 8: Skeletonized images of vascular networks. A) Normal arteries and veins. B) Normal subcutaneous 
capillaries. C) Tumor vasculature [43]. 
Saito et all showed that the number of branching point for unit area was 
significantly higher in tumor than normal tissues [44]. 
Jain et all introduced a tumor vessel classification and provide the first quantitative 
measurement of vessel branching patterns and the related vascular dimensions in a 
mammary carcinoma. They 
assigned a number, corresponding 
to an order, to each vessels of a 
vascular structure. The feeding or 
draining vessel is assigned to order 
1. The angle of bifurcation 
determines the classification of the 
daughter vessels. If a vessel continues past the bifurcation at an angle of 160-180 
degrees, then it retains the same order; otherwise, it is assigned to the next higher 
branching order. To enter a true loop, this angle determines the order of the vessels 
in the loop because all segments are assigned to the same order. In a self-loop, the 
two daughter vessels retain the same order as the parent, and when the daughters 
Fig. 9: Vessels branching pattern and relative orders [16]. 
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converge they also retain the same order. At a trifurcation, the branch angle rules 
are applied to the two pairs of vessels, each of which includes the middle vessel 
(Fig.9). For each branching order, they measured vessels diameter and length. 
Furthermore they showed that heterogeneity in vascularization of tumors results in 
diverse local microenvironments for the tumor cells and could drastically affect the 
efficacy of cancer therapies [41]. An important variable is that blood flow through 
tumors does not follow a constant, unidirectional path. Not all open vessels are 
perfused continuously, and, over a few minutes, blood flow may follow different 
paths and even proceed in alternating directions through the same vessel [39]. 
 Desmoplastic reaction in cancer 
Increased mammographic density is one of the greatest risk factors for the 
development of breast cancer, representing a two- to six-fold increase in tumor 
susceptibility among women with dense breasts. The increased density is due 
largely to an elevated collagen concentration, and is commonly identified in the 
mammogram as a general increase in X-ray absorbance throughout the entire breast 
[45]. Keely et al demonstrated that collagen density correlate positively with both 
tumorigenesis and tumor progression [46]. One of the features of breast cancer is 
the desmoplastic reaction, responsible for the clinical presentation of a tumor as a 
‘lump’[47]. The phenomenon is characterized by amplified collagen matrix 
deposition and stromal cell recruitment and activation (e.g. fibroblasts, 
myofibroblasts and macrophages) [45]. The stromal reaction occurs with the 
increase in dense fibrotic or connective tissue rich in collagen and other ECM 
macromolecules including specific species of proteoglycans and hyaluronic acid 
surrounding the tumor mass [48]. The reorganization of the stromal network is 
primarily mediated by stromal cells, most prominently fibroblasts. Cancer-
associated fibroblasts (CAFs) reorganize the stroma by secreting ECM elements 
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and enzymes that covalently cross-link collagens fibers and by physically pulling 
on the collagen network. As a result, the stromal network becomes stiffer. In breast 
cancers, neoplastic tissue can be two- to ten-fold stiffer than normal tissue. This 
increase in tissue stiffness is thought to primarily reflect changes in the stroma, 
while tumor cells themselves appear to become softer [49].  
The exact role of the desmoplastic reaction associated with cancer development is 
not known. However, it has been proposed to represent either a defense mechanism 
by normal host cells against invading cancer cells or to be a tumorigenesis 
promoting phenomenon induced by cancer cells to assist their propagation [48]. 
As collagen content, fiber structure, and organization are potentially key 
determinants of tumor cell behavior Keely et al employed nonlinear optical 
imaging of tumor-stromal interactions in intact live tumors by Multiphoton laser-
scanning microscopy (MPLSM) in order to identify specific Tumor-Associated 
Collagen Signatures (TACS). They defined three signatures. Specifically: 
- TACS-1, the presence of locally dense collagen within the globally 
increased collagen concentration surrounding tumors, indicated by increased 
signal intensity at a region near the tumor, which serves as a reliable hallmark 
for locating small tumor regions; 
- TACS-2, straightened (taut) collagen fibers stretched around the tumor, 
constraining the tumor volume; 
-  TACS-3, identification of radially aligned collagen fibers that facilitate 
local invasion [46].  
Furthermore, because of the strong statistical evidence for poor survival in patients 
with TACS, and because the assessment can be performed in routine 
histopathological samples imaged via second harmonic generation or using 
picrosirius, they proposed that quantifying collagen alignment could be a viable, 
novel paradigm for the prediction of human breast cancer survival [45]. 
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However, the desmoplastic response is nearly an exclusively human occurrence, 
being quite rare among spontaneous and transplantable animal tumors and absent in 
most human tumoral xenografts in athymic `nude' mice. Difficulties in the study of 
the phenomenon arise from the lack of a good experimental model where the 
desmoplastic response occurs and can be successfully perturbed [47]. Barsky et al 
hypothesized two explanations for the absence of desmoplasia in human 
xenografts. The first was that the rapid growth of the tumor cells might overwhelm 
any host stromal response. The second was that breast carcinoma cell lines could 
lose their desmoplasia-inducing phenotype with increasing in vitro passage through 
the loss of critical gene products such as paracrine growth factors. Despite classical 
model fail to reproduce desmoplastic reaction, some transgenic models are 
effective for the study of the phenomenon. For their studies, Barsky et al used c-
ras
H
 transfected Human Breast Adenocarcinoma cells (MCF-7) which overexpress 
ras p2l. Their results suggest that breast carcinoma-secreted PDGF is the major 
initiator of tumor desmoplasia [47].  
Keely et al demonstrated that mammary tumor formation, invasion and metastasis 
are enhanced in collagen-dense stroma in a bi-transgenic mouse model with 
increased stromal collagen in mouse mammary tissue [46]. 
However, further studies are needed to better clarify the exact role of desmoplastic 
reaction in tumors before it is possible to fully assess whether desmoplastic 
reaction associated molecules might provide a target in the treatment of cancers. 
This could be of central interest also because the excessive ECM deposition due to 
fibrotic remodeling physically hinders diffusion of large anti-tumoral molecules 
through the interstitium [35]. 
Sainio and Järveläinen presented some examples of strategies how ECM 
macromolecules involved in desmoplastic reaction could be considered in the 
development of innovative oncological pharmacotherapies in the future [48]. 
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2.1.3 Cancer cells metastasis 
Metastasis is a hallmark of cancer and the leading cause of mortality among cancer 
patients. Cancer is not only a disease of uncontrolled cell growth, but also a disease 
of uncontrolled cell migration. The first step in metastasis is the migration of 
cancer cells away from the primary tumor, a process called tumor invasion. In 
solid epithelial tumors, invading cells must first cross the basement membrane 
(BM). It is a natural barrier between the epithelium and the stroma, a network of 
ECM populated by a number of other cell types that surround the tissue. 
Metastasizing cells migrate through the stroma to reach blood or lymph vessels, 
where they are able to enter and to be carried to other organs (Fig.10) [49]. 
 
Fig. 10: Summary of tumor progression and invasion. In invasive tumors, cancer cells perforate the BM or 
migrate through regions of dysfunctional BM deposition, allowing the tumor cells to invade the stroma 
and migrate toward the blood stream [49] . 
 Interstitial cancer invasion 
In vitro and in vivo observations have shown that tumor cells infiltrate neighboring 
tissue matrices in diverse patterns. When cell-cell contact are absent, cells can 
disseminate as individual cells, referred to as ‘individual cell migration’, whereas 
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when cell-cell adhesions are retained, cells can expand in solid cell strands, sheets, 
files or clusters, called ‘collective migration’[50]. Cancer cells possess a unique 
ability to adapt to different environmental conditions, assuming different 
morphologies and migration characteristics in order to stay motile. In human cancer 
pathology studies, cancer cells from epithelial tumors primarily invade collectively. 
Intravital imaging studies show that cancer cells display a wide range of different 
migration modes and morphologies. In vitro studies have identified several intrinsic 
factors regulating migration mode and morphology. In cancer cells migrating 
individually, increased contractility, under control of the Rho-pathway, favors 
amoeboid-like migration, while lower contractility (and/or increased adhesion) 
favors more mesenchymal phenotypes. Increased cell-cell interactions via 
cadherins and cell- ECM binding via integrins can promote collective migration in 
cancer cells. In addition to intrinsic factors, the microenvironment plays a 
significant role in determining cancer cell migration mode and morphology [49]. 
Friedl and Alexander talk about cancer cell invasion like a heterogeneous and 
adaptive process in which “plasticity” in cell adhesion, cytoskeletal dynamics, and 
mechanotransduction perpetuates migration and dissemination under diverse 
structural, molecular, and even adverse microenvironmental conditions. Such 
heterogeneous tumor progression is mirrored by the ‘‘activation’’ response of 
stromal cells nearby the growing tumor, including fibroblasts, endothelial cells, and 
macrophages. These cells reorganize the structure and composition of the 
connective tissue by depositing ECM, cytokines, and growth factors. By 
remodeling the tissue structure, releasing growth factors, and imposing metabolic 
stress, the reactive tumor stroma, in turn, influences cancer cell functions, often 
enhancing tumor growth and invasion and aggravating cancer resistance during 
metabolic challenge and therapy. Thus, in a reciprocal manner, tumor cells 
influence the stroma and vice versa, jointly driving cancer progression. The 
mechanisms of tumor cells migration recapitulate those of normal, non-tumor cells 
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but neoplastic cells lack physiological “stop signals” immobilizing and anchoring 
the cells [51].  
Individual-cell migration can be mesenchymal or amoeboid. Cells can move alone 
or in multicellular streaming when are one after each other following the same 
path. Collective 
invasion may 
adopt different 
morphologies. 
Groups of cells 
can form small 
clusters, solid 
strands, or files; 
if epithelial 
polarity is 
retained during 
migration, these 
structures can 
even form an 
inner lumen. In 
most cases of 
collective cancer 
invasion, one or 
several leader 
cells with 
mesenchymal 
characteristics 
form the tip of 
multicellular strands and generate forward traction and pericellular proteolysis 
Fig.11 Modes of cell movement implicated in cancer invasion and metastasis [51] 
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toward the tissue structure. In a second type of collective invasion, a blunt bud-like 
tip protrudes along tissue space consisting of multiple cells that variably change 
position, lacking defined leader cells. The mechanism of expansive growth occurs 
when surrounding tissues impose little to no physical confinement on proliferating 
tumor cells and thus do not hinder the expansion of a cancerous lesion. When 
tumor cells grow in this way, the increase in volume leads to multicellular outward 
pushing with intact cell-cell junctions and no signs of active migration (Fig.11) 
[51]. Tumor cells can migrate assuming these different morphologies determined 
by the cell type but they can also switch migration mode depending on the 
microenvironment conditions or assume intermediate phenotypes. 
The most well-established example of changes in cancer-cell pattern and function 
is termed the Epithelial–Mesenchymal Transition (EMT). Following tumor 
progression and dedifferentiation, epithelial cancer cells can undergo a transition 
from a collective invasion pattern towards a detached and disseminated cell 
migration mechanism. These cells move in a fibroblast-like fashion [50]. Complete 
EMT is defined by a metastable, fibroblastoid phenotype plus loss of E-cadherin 
and gain of vimentin and it was most closely correlated with local invasion and 
metastasis [52]. EMT is also thought to represent a program transiently controlled 
by the microenvironment, which locally downregulates epithelial characteristics 
and facilitates cell escape from the primary tumor. However, with local upstream 
signaling lost, cells can undergo mesenchymal-to-epithelial reversion after 
metastatic seeding in the secondary organ. Thus, EMT-dependent invasion and 
metastasis programs are strongly responsive to microenvironmental changes and 
adaptive in their signaling program and associated invasion dynamics [51]. 
The understanding of these mechanisms is fundamental to investigate the 
mechanisms of drug resistance and develop new therapies for the treatment of 
metastatic tumors. 
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 Intravasation 
Tumor cells can penetrate blood or lymphatic vessels, circulate through the 
intravascular stream, and then proliferate at another site: metastasis [53]. So, after 
the interstitial migration, invading cancer cells enter the circulation by migrating 
directly through blood vessels walls (intravasation). If they survive the shear stress 
and the protective immune cells in the bloodstream, they can eventually attach to 
the endothelium that line the blood vessels. This process frequently involves 
leukocytes and platelets. Circulating cancer cells usually extravasate and then start 
to proliferate in the stroma. However, in some cases they initially proliferate in the 
blood vessels, then cross the endothelium and invade the underlying tissues as 
groups (micro-metastasis). Intravasation and extravasation of cancer cells both 
require the disruption of endothelial junctions for the cancer cells to cross the 
endothelium — a process that is known as transendothelial migration (TEM) — but 
intravasation and extravasation are fundamentally different because the cancer cells 
approach the endothelium from opposite sides. To intravasate, tumor cells need to 
invade through the tissues towards blood vessels. Otherwise tumors inducing local 
angiogenesis can enter the vasculature through new blood vessels generally having 
weak cell–cell junctions. 
Tumor cells can cross the endothelial wall by paracellular intravasation or 
transcellular intravasation. Paracellular intravasation involves the disruption of 
endothelial junctions and in particular the cleavage of vascular endothelial 
cadherins (VE-cadherins) by metalloproteinases or their retraction. Tumor 
associated macrophages can attract cancer cells towards blood vessels by secreting 
epidermal growth factor (EGF) and can also secrete tumor necrosis factor 1α 
(TNF1α), which induces the retraction of endothelial junctions. Cancer cells can 
use Notch receptors to bind to Notch ligands on ECs and thereby transmigrate 
through the endothelial junctions; they can also secrete transforming growth factor 
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β1 (TGFβ1), which induces the retraction of endothelial junctions. During 
transcellular intravasation, the Ca2+ –calmodulin complex in an EC activates 
myosin light chain (MLC) kinase (MLCK) at the sites of cancer cell attachment, 
which leads to local phosphorylation (P) of MLC and to actomyosin contraction. In 
turn, this leads to rapid cytoskeletal and membrane remodeling, which creates a 
transitory pore-like structure for the cancer cell to cross the EC (Fig.12) [54]. 
Another paradigm for tumor intravasation suggested by Weider, citing Sugino et al, 
is that, in some tumor models, tumor cells can gain access into blood vessels by 
intravasation of tumor cell nests surrounded by vascular endothelial cells, followed 
by intravascular tumor growth without penetration of the vascular wall. This 
concept depends from the evidence that intratumor micro-vessel density correlate 
with aggressive tumor behavior and the greater number of tumor vessels increases 
the opportunity for tumor cells to enter the circulation. They suggested that high 
angiogenic activity and sinusoidal remodeling of tumor blood vessels around tumor 
cells are prerequisites for tumor metastasis [55]. 
 
 
Fig. 12: Mechanisms of transendothelial migration: paracellular or transcellular intravasation [54]. 
In the bloodstream of patients with metastatic epithelial cancer both single and 
cluster circulating tumor cells (CTCs) are present. CTCs-clusters describe groups 
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of 2-50 cancer cells [56]. Using mouse models with tagged mammary tumors, 
Maheswaran et al demonstrated that CTCs-clusters arise from oligoclonal tumor 
cell groupings and not from intravascular aggregation events. Although rare in the 
circulation compared with single CTC, CTCs-clusters have 23-50-fold increased 
metastatic potential. In breast cancer patients, both abundance of CTCs clusters and 
high levels of the cell junction plakoglobin denote adverse outcomes [57]. Toner et 
al used engineered microfluidic constriction devices with dimensions mimicking 
human capillaries to study the behavior of CTCs clusters within constrictions under 
physiological temperature and pressures. They found that CTCs clusters 
successfully traversed 5- to 10-μm constrictions even in whole blood. Clusters 
rapidly and reversibly reorganized into single-file chain-like geometries that 
substantially reduced their hydrodynamic resistances. They performed also in vivo 
studies by xenotransplantation of human CTCs clusters into zebrafish and showed 
similar reorganization and transit through capillary-sized vessels. In their work, 
preliminary experiments demonstrated that clusters could be disrupted during 
transit using drugs that affected cellular interaction energies. Beyond their role in 
metastasis, CTCs clusters may also serve as biomarkers for early detection, as 
prognostic markers, may have utility for non-invasively tracking changing drug 
susceptibilities in patients undergoing treatment and for the development of new 
therapeutic approaches [58]. It is not clear whether CTCs clusters passively enter 
the bloodstream through compromised tumor vasculature or whether they actively 
traverse the endothelial cell barrier as observed in collective cell migration 
phenomena [59]. One possible entry way of CTCs cluster into the bloodstream 
could be the shedding from mosaic vessels [60]. 
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2.1.4 Models for breast cancer research  
Historically, cancer has been studied in two dimensional (2D) monolayer cultures 
and small animal models [61]. When cultured in vitro, cancer cells lose many of 
their in vivo features, because of the lack of environmental signals present in native 
tumors [32]. 2D cell culture models lack the structure for proper cell–cell and cell–
matrix interactions and are not able to replicate the in vivo phenotype which is 
strongly influenced by the microenvironment [29]. Animal models also have 
limitations, as they often fail to represent the pathology of human tumors [32]. In 
fact, there exist major differences between cancer progression in humans and 
animals. Moreover, using animals can be very costly, laborious, and requires 
animal facilities as well as Institutional Animal Care and Use Committee approval. 
Recently, there has been promising published work on three-dimensional (3D) cell 
culture models developed to study breast cancer tumor progression in vitro [29] 
[62]. Bissels and Nelson talk about not simply a culture model but a new paradigm, 
that tissue-specific functions can be recapitulated in the laboratory by providing 
cells with appropriate microenvironmental cues that allow the rebuilding of tissue-
specific form. They have been one of the pioneers to use 3D to model the murine 
gland in both its normal and diseased state [63].  
 In vitro 3D models in cancer research 
3D in vitro culture systems to model tumors can be mainly classified into cells 
cultured as multicellular aggregates and cells embedded in construct made of 
natural or synthetic matrices (Fig.13).  
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Fig.13: Schematic picture of A) a tumor and B) different tumor models [29]. 
 
In addition high-throughput technologies such as microfluidic devices have been 
developed to model tumors and the influence of the microenvironment [29]. 
Another culture system involve cells seeding on fibroblast derived 3D matrices 
with the aim to mimic the native 3D environment [64].  
- Multicellular aggregates 
In 1966, Halpern et al cultured cancer cells in suspension using an Erlenmeyer on a 
shaker – the Moscona’s technique – and showed that malignant cells have higher 
capacity to aggregate than normal cells. For a long time cancer biologists have 
modeled cancer in cell aggregates or spheroids, using Moscona’s technique [32]. 
Spheroids have been widely used in the cancer field as a model system in several 
studies involving 3D cell culture for drug screening predominantly for high-
throughput applications. Spheroids are 20–1000 μm diameter clusters of cells that 
self-aggregate when cultured in rotary wall vessels or spinner flasks. Spheroids 
have been shown to preserve the physiological shape of the tumor, respond to 
chemotherapy and radiation therapy, and maintain tissue-specific properties of the 
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primary tissue. Several techniques have been presented in the literature for 
culturing spheroids. The most widely used techniques involve growing cells on 
plates coated with low attachment substrates to prevent cell–substrate interaction, 
in hanging drops, or in a continually rotated suspension such as a spinner flask. 
However, these techniques are time consuming and hard to standardize [29]. 
Moreover, it was demonstrated that spheroids contain few or no stromal elements 
[65]. In 2011, a new method to culture spheroids from primary cancer cells was 
developed by Kondo et al. Tumors were dissociated mechanically and 
enzymatically to isolate cancer cells and make cancer tissue originated spheroids 
also known as ‘tumor organoids’. Tumor organoids are important for displaying the 
typical histological characteristics of the original tumor and for their ability for 
seemingly indefinite expansion in vitro [32]. Ewald et al developed three-
dimensional organoid assay to identify the most invasive cancer cells in primary 
breast tumor. Tumor organoids in Collagen I hydrogel were used as experimental 
model. They found that basal epithelial markers, including Keratin14 (K14) and 
p63, are expressed in the invasive leader cells leading collective invasion and that 
the knockdown of either K14 or p63 was sufficient to block cells migration into 
collagen [66].  
- Cells embedded in construct made of natural or synthetic matrices 
The 3D culture techniques usually include adding cell suspension to matrices or 
culturing cells on biomaterial scaffolds that can be fabricated into various desired 
architectures from different materials. Hydrogel matrices, such as Matrigel and 
type I collagen, and synthetic matrices have been widely used to investigate how 
the physical properties of the ECM modulate tumor cell invasion [29]. Matrigel is a 
basement membrane formulation derived from the Engelbreth-Holm-Swarm mouse 
sarcoma. In some works, Matrigel and collagen are used in combination. 
Sonnenschein et al have underlined the role of both the ECM composition and the 
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presence of fibroblasts in determining the fate of the epithelial cells and their 
phenotype [67]. Beebe et al incorporated human mammary fibroblasts and breast 
cancer cells in a 3D co-culture model based on collagen and Matrigel, modeling the 
progression from ductal carcinoma in situ to invasive ductal carcinoma [68]. 
Matrigel has been long used for invasion assay but several studies have identified 
batch-to-batch variations that cannot be controlled and can be problematic when 
interpreting results from studies [29].  
Overall, native scaffold effectively promoted cell adhesion and growth [32]. Using 
porous collagen I scaffolds breast cancer cells recapitulate many of the tumor 
features: morphology, proliferation, overexpression of pro-angiogenic factors, and 
MMP transcriptions [69]. However, most of the 3D in vitro models fail to 
reproduce tumor complexity and plasticity, because they use homogeneous and 
passive scaffold [70] whose properties cannot be altered easily to interrogate the 
contributions of specific environmental cues to tumor assembly [71]. Another 
shortcoming of classical model is the lack of vascularization limiting diffusion 
properties of nutrient and oxygen, the size of engineered tumors, and cancer cell 
viability and function. Vascularization is also required for tumor metastasis. A 
number of approaches have sought to co-culture cancer cells, endothelial cells and 
supporting cells in order to create vascularized tumor models [32]. Rylader et al 
showed that paracrine signaling between telomerase-immortalized human 
microvascular endothelial (TIME) cells cultured as an endothelium on the surface 
of an acellular collagen I hydrogel and MDA-MB-231 cells cultured beneath in a 
separate collagen I hydrogel led to augmented angiogenic activity; specifically a 
significant increase in TIME cell number, the development of an elongated and 
aligned TIME morphology, and invasive angiogenic sprouting [72]. A particularly 
interesting tumor model was developed by tumor cells (breast and colon), human 
fibroblasts and endothelial cells cultured in fibrin matrix, resulting in a network of 
sprouting vessels, and cancer cells invasion of the surrounding matrix. In detail 
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George et al introduced the Pre-Vascularized Tumor (PVT) model to investigate 
early events of solid tumor progression. PVT spheroids were composed of 
endothelial and tumor cells, and were embedded in a fibrin matrix containing 
fibroblasts. The PVT model allowed robust sprouting angiogenesis into the matrix, 
and contiguous vascularization within the spheroid. Furthermore, the PVT model 
enabled the intravasation of tumor cells that was enhanced under low oxygen 
conditions and was also dependent on the key EMT transcription factor Slug [73]. 
Also synthetic materials have been widely used by cancer biologists and engineers. 
Synthetic biomaterials can be fabricated in a reproducible manner and in large 
quantities. Some of the commonly used synthetic biomaterials to generate breast 
cancer models include poly (lactide-co-glycolide) (PLG), poly (lactic acid) (PLA), 
and poly (ethylene glycol) (PEG). Paszek et al found that combining 
polyacrylamide gels with ECM components and changing the elastic moduli can 
disrupt epithelial tissue homeostasis, potentially leading to malignant behavior. 
Fischbach et al, Cross et al, and Szot have engineered 3D in vitro tumor models 
using both natural and synthetic polymeric scaffolds, respectively, showing that 
endothelial cells can remodel dense type I collagen matrices in response to 
angiogenic factors from cancer cells, and the different effects of these angiogenic 
factors on drug responsiveness [29]. 
Recent advances in microfluidic technology have made it possible to develop 
innovative assays that enable accurate control of the cellular microenvironment. 
Microfluidic assays are highly beneficial toward clinical applications since they are 
high throughput and automated, thus requiring minimal manual operations during 
measurements. Recently our group proposed a new model of breast cancer 
featuring both epithelial and stromal tissues arranged on a microfluidic chip. The 
model recapitulate the fibroblasts activation and ECM remodeling following tumor 
invasion into a microfluidic system which allows to quantify in real time the switch 
between a healthy to a pathologic status in vitro at ECM level [74].  
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Several 3D models have been established using microfluidic devices to study 
metastatic events. Polacheck et al exploited a microfluidic cell culture system to 
investigate the effects of interstitial flow on tumor cell migration and found that 
breast cancer cells migrated in an organized fashion with interstitial flow as 
compared to control devices without flow where cells migrated randomly. 
Moreover, several investigators have applied microfabrication technologies to 
obtain engineered biomimetic vasculature in order to simulate physiological 
transport phenomena. The main objective of these studies was to characterize the 
processes activated by cancer cells under shear stress conditions: adhesion with 
endothelial cells and degradation of the basement membrane to undergo metastatic 
growth [29]. 
Kamm et al presented a unique approach using a microfluidic-based in vitro assay 
that enables real-time visualization and quantification of the interactions between 
tumor cells and an endothelial monolayer in the context of tumor cell invasion and 
intravasation. They showed that the endothelium poses a barrier to tumor cell 
intravasation that can be regulated by factors present in the tumor 
microenvironment [75]. 
Hughes et al developed a microfluidic micro-physiological system that incorporates 
human tumor and stromal cells in a 3D ECM, supported by perfused human micro-
vessels. Through this microfluidic device they were able to deliver anti-angiogenic 
drugs and evaluate their effect on vasculature supporting tumor growth [76]. Their 
platform was constructed using standard photolithography from PDMS and 
consists of two outer microfluidic channels that act as arteriole (high pressure) and 
venule (low pressure), connected by three tissue chambers, into which it was 
injected a slurry of ECM and cells. Over the course of 5–7 days ECs self-assemble 
into an interconnected network that anastomoses with the outer channels resulting 
in the passage from interstitial to intraluminal flow [77] [78] [76]. 
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- Cells seeded on fibroblasts 3D derived matrices 
Because in vitro collagen matrices, Matrigel, and other synthetic support systems 
do not closely resemble the mesenchymal microenvironment that is typically 
associated with advanced carcinomas in vivo, several groups have evaluated the 
ability of fibroblast derived 3D matrix to regulate the growth and invasion skills of 
human tumor epithelial cell lines. Cukierman et al proposed the use of 
decellularized NIH-3T3 derived matrices as in vitro drug screening platforms [79]. 
Another work showed that harvested primary stromal fibroblasts, obtained from 
different stages of tumor development, did not retain in vivo stromagenic 
characteristics when cultured on traditional 2D substrates but they were capable of 
effectively maintaining the tumor-associated stromal characteristics within 3D 
cultures. They demonstrated that in vivo-like 3D matrices appear to have the 
necessary topographical and molecular information sufficient to induce the 
activation normal fibroblasts [80].Moreover, they compared early and late 3D 
matrices respectively produced by NIH-3T3 and tumor-associated murine 
fibroblasts. After removing fibroblasts, extracted matrices were re-cultured with 
breast epithelial cells of assorted characteristics: MCF-10A (non-tumorigenic), 
MCF-7 and MDA-MB-231 (tumorigenic). They observed that assorted breast 
epithelial cells reacted differently to 2D vs 3D matrices. MCF-10A had a 
proliferative advantage on 2D substrates while MCF-7 and MDA-MB-231 showed 
no difference. MCF-10A and MCF-7 formed morphologically distinguishable 
aggregates within 3D matrices, while MDA-MB-231 exhibited increased spindle-
shape morphologies and directional movements within three-dimensional matrices. 
Furthermore, MDA-MB-231 acquired a pattern of parallel oriented organization 
within tumor-associated, but not control matrices .[81] 
49 
 
Based on the idea that stroma and stromal fibroblasts have a fundamental role in 
both physiological and 
pathological tissuegenesis, 
our group, Netti et al, 
developed a new strategy to 
produce pieces of viable 3D 
tissue-equivalent to resemble 
and capture the major 
features of native tissue. In particular, micro-tissues (µTPs) were obtained by 
means of dynamic cell seeding of fibroblasts on porous gelatin micro-carriers using 
a spinner flask bioreactor. With this approach, it is possible to guide the process of 
collagen deposition and assembly within the extracellular space and match it with 
scaffold degradation, cell traction and tissue maturation in order to obtain firmer 
collagen network. In this way, it could be possible develop tumor micro-tissue with 
controlled microarchitecture and significant ECM components. The presence of the 
micro-scaffold in this micro-tissue induces collagen synthesis and sustains its 
assembly reproducing the tumor architecture found in vivo. By following the 
dynamic seeding approach cancer associated fibroblasts-µTPs were produced 
showing a strong second harmonic generation signaling (SHG) compared to 
spheroid demonstrating the production of collagen (Fig.14). This is extremely 
important in the effort of mimicking the behavior of some tumor types featured by 
a dense desmoplastic stromal reaction [65].  
Fig. 14: A)CAF spheroids and B) CAF µTPs [65]. 
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2.2 Physiological tissue: Human skin 
2.2.1 Human skin: In vivo overview 
The skin consists of a highly differentiated stratified epithelium, the epidermis, and 
a scaffold of connective tissue which is rich in neurovascular structures, the dermis. 
The latter is based on a fatty tissue arranged in lobules, the hypodermis. Also 
epithelial structures, which together are referred to as skin appendages, are part of 
the skin: the pilosebaceous units, the sweat glands and nails (Fig.1). The skin is a 
complex organ with specific functions and activities such as: thermoregulatory and 
sensory activity, barrier, deposit, metabolic, endocrine and secretory functions and 
it is involved in the maintenance of the homeostasis pressure [82].  
 
 
Fig. 1: Schematic representation of the skin. 
The epidermis is a keratinized stratified epithelium without blood vessels. The 
epidermal cells are especially keratinocytes. It is composed by 5 layers and it is 
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connected to the dermis by a basement membrane. The deepest layer or basal 
consists of proliferating cells (germinal layer) which divide by mitosis to produce 
the majority of the epidermal cells and differentiate toward the external layer. The 
5 layers of the epithelium are: basal stratum, spinosum, granulosum, lucidum and 
corneum. During development of epidermal layers, keratinocytes became 
anucleate, change shape and become highly organized, forming cellular junctions 
(desmosomes) between each other and secreting keratins [83].  
The dermis is a dense irregular connective tissue populated by fibroblasts and other 
cells residing in an Extracellular Matrix composed of collagen (mainly types I and 
III), elastic fibers, glycosaminoglycans (GAGs), proteoglycans (PGs), and other 
minor components [84]. The dermis comprises 2 distinct layers: The layer that is 
closest to the epidermis, known as the papillary (or upper) dermis, has thin collagen 
fibers, below that lies the reticular (or deep) dermis, which has dense collagen 
fibers, and overlies the subcutaneous fat layer [85]. 
2.2.2 Skin microenvironment 
The basal layer of the epidermis is attached to a basement membrane [85] mainly 
consisting of collagen IV, laminin, nidogen/entactin, and perlecan [86]. The 
underlying dermis is a thick layer of connective tissues (until 3.0 mm on the back) 
that consists mainly of ECM or structural components (predominantly collagen and 
elastin) which give mechanical strength and elasticity and a vascular plexus for 
skin nourishment. Cells interspersed within the ECM include fibroblasts, 
endothelial cells, smooth muscle cells and mast cells [87].The ECM is produced by 
stromal fibroblasts and provides structural scaffolding for cells, as well as 
contextual information [88].Research on the structure and composition of the ECM 
strongly indicates that the major role of this matrix is in regulating cell/cell 
communication rather than in passively supporting cells. A wealth of structural 
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data on the ECM suggests that there are specific arrangements of sequences within 
these proteins which profoundly influence the behavior of the cells moving in that 
area, with respect to attachment, migration, differentiation and proliferation. In the 
skin, the ECM can be argued to promote 'appropriate' communication between the 
keratinocyte and the fibroblast [89]. So, ECM constituents are essential for 
providing tissue structural integrity and regulate cellular functions cell-cell and 
cell-matrix interactions, and serve as a reservoir and modulator of cytokines and 
growth factors’ action [90]. 
 Vascularization of the skin  
The cutaneous microvasculature is composed by arterioles and venules forming 
two important plexuses in the 
dermis: an upper horizontal 
network in the papillary dermis 
from which the nutritive capillary 
loops of the dermal papillae arise 
and a lower horizontal plexus at 
the dermal-subcutaneous 
interface. The lower plexus, 
formed by perforating vessels 
from the underlying muscles and 
subcutaneous fat, gives rise to 
arterioles and venules that directly 
connect with the upper horizontal 
plexus and also provide lateral tributaries that supply the hair bulbs and sweat 
glands. The micro-vessels in the papillary dermis vary in diameter from 10 to 35 
µm whereas in the lower dermis diameters are wider, of about 50 µm Some 
Fig. 2 Representation of the microvascular 
organization in human skin. E, epidermis; A, arteriole; 
V, venule; F, subcutaneous fat 
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interconnections are present among the ascending arterioles and descending 
venules within the dermis (Fig 2) [91]. Arteriovenous anastomoses (AVAs) are 
special feature of human skin microcirculation [92]. The arteriolar wall is formed 
by three layers: the ‘adventitia’, with collagen and elastic fibers, the ‘media’ with 
smooth muscle cells, and the ‘with collagen fibers and endothelium. When the 
arterioles become smaller, the layer of smooth muscle cells becomes discontinuous 
(meta-arterioles) and it is replaced by pericytes at the capillary level. Capillaries are 
formed by a basal lamina, pericytes and endothelial cells. The post-capillary 
venules initially have the same structure of the meta-arterioles, but the basal lamina 
surrounding the endothelium is multilayered and sometimes collagen bundles are 
observed between the basal lamina and smooth muscle cells. Venules of greater 
caliber have a thicker ‘media’ and an ‘adventitia’ with an elastic basement 
membrane [82]. 
2.2.3 In vitro skin models 
Over the past 30 years Tissue Engineering has made numerous efforts to get 
substitutes that mimic the structure and function of human skin. 
The first stage of the general strategy for obtaining the skin-equivalent models 
involves fibroblasts and keratinocytes extraction from skin biopsies and their 
amplification in 2D cultures in vitro. Fibroblasts are seeded within a scaffold able 
to mimic the functions of the extracellular matrix and kept in 3D cultures for the 
realization of the dermal component of the skin. Following keratinocytes are 
seeded on the surface of the scaffold and maintained in culture in order to obtain a 
stratified and differentiated epithelium (Fig.3). 
Dermo-epidermal substitutes have many applications both in vivo and in vitro. In 
fact they may be used for clinical applications and as platform for drug or cosmetic 
screening [93]. 
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Fig. 3 Schematic illustration of principles of skin tissue engineering. Primary keratinocytes and 
fibroblasts are isolated from human donor tissues. For a full-thickness skin equivalent, the fibroblasts 
and the matrix are initially used to establish the dermal part. The keratinocytes are seeded afterwards 
on the top of the dermis to ultimately form the epidermal part of the skin substitute. The in vitro-
engineered skin can serve as skin graft or can be used as human-cell based in vitro test system [93]. 
Recently our group showed the importance of an endogenous dermis compartment 
in tissue formation and function in vitro. The dermis was obtained using a bottom 
up approach. The strategy for the construction of biohybrid dermis equivalent was 
described in a paper published by Palmiero et al in 2010 and it is based on the 
principle that most of the tissues in vivo are composed by repeating units of 
dimensions in the order of µm, consisting of different cell types and with a μ-
architecture and tissue-specific functions. The bottom up approach allowed to 
obtain thick and viable 3D tissues starting from the assembly of µ-Tissue-
Precursors (μTPs) obtained via dynamic seeding and culture of fibroblasts on 
porous gelatin micro-spheres. Fibroblasts from human skin biopsies were 
dynamically seeded and cultured on gelatin porous µscaffolds into Spinner Flask. 
Cells were able to adhere on the surface and into the pores of the scaffold and here 
to proliferate and produce elements of the extracellular matrix (ECM) and in 
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particular collagen I. Thanks to cell-cell and cell-matrix interactions, adjacent μTPs 
were able to increase their size and coalesce, forming larger tissue precursors. To 
get the biohybrid dermis- equivalent, μTPs were assembled into specific maturation 
chambers and kept in dynamic culture regime (Fig.4). 
 
Fig. 3 Scheme of the bottom-up process (A); assembling chamber drawing (B), showing the configuration 
of the assembling chamber during the µTPs assembling process (a), the silicon mold with four empty 
spaces (b), the rigid mesh with 18 lm pore size (c) and the PTFE ring (d); μTPs loading (C) [21]. 
In a following work, Imparato et al demonstrated that the mechanical properties 
and the degradation rate of the scaffold impact on the organization and maturation 
of the de novo synthesized collagen. In particular, they showed that modulating the 
density of crosslinking is possible to drive the processes of collagen deposition and 
assembly as well as to balance the degradation rate of the scaffold with tissue 
maturation and cell traction. The use of micro-scaffolds crosslinked with 4% of 
glyceraldehyde allowed to obtain a massive deposition of immature collagen 
progressively assembled in mature collagen fibrils. The relationship between the 
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degradation time of the scaffold and the synthesis of collagen was just below the 
unit by determining an intermediate tissue ability to resist contraction [94].  
Seeding human keratinocytes on this kind of matrix allowed obtaining a functional 
skin equivalent model in which it is possible to generate follicle-like structures in 
vitro resembling what occurs in vivo in the fetal skin. Thus, supporting the 
importance of the repository and regulatory role of the endogenous extra cellular 
matrix in guiding tissue morphogenesis [22].  
 Skin substitutes for clinical application 
Research in skin tissue engineering was initially prompted by the need to obtain 
substitutes for the care of patients with extensive damaged tissue area. There are 
multiple reasons for skin damage including genetic disorders, acute trauma, chronic 
wounds (e.g. lower extremity ulcers, decubitus ulcers, chronic venous or diabetic 
foot ulcers) or surgical interventions. One of the most common causes for major 
skin injury is thermal trauma (e.g. burns). In many cases, it is not possible to carry 
out the autograft because of the extension of the damaged are (> 50% -60% of the 
total body surface area, TBSA) and for the possibility of infection at the implant or 
graft site. The tissue engineering challenge is to obtain a skin model transplantable 
quickly, in large quantities, possibly during a single surgical intervention and 
without production of significant scarring [93] [95] [87].  
Currently clinically available models are represented by epidermal, dermal or 
dermo-epidermal substitutes. These models can be used alone or in combination in 
order to repair damaged skin tissue. 
The first step in skin tissue engineering was the in vitro culture of keratinocytes 
after enzymatic separation of the epidermis from the dermis [96] 
Rheinwald and Green managed to grow human primary epidermal cells in serial 
culture on a layer of lethally irradiated 3T3 murine fibroblasts demonstrating the 
57 
 
importance of the crosstalk between keratinocytes and fibroblasts [97]. O’Connor 
et al. reported the world’s first grafting of extensive burns with sheets of cultured 
epithelium expanded from autologous epidermal cells (CEA).  
Burke et al. reported afterwards the successful use of an artificial dermis in the 
treatment of extensive burn injuries. This artificial dermis is now known as Integra 
and it is made up of bovine collagen and chondroitin 6-sulfate [87]. Another dermis 
substitutes is Matriderm which is an acellular lyophilized collagen and elastin 
based biomatrix [98]. In addition to these acellular matrices, there are some cellular 
substitutes such as Apligraft It is constructed by culturing human foreskin-derived 
neonatal fibroblasts in a bovine type I collagen matrix over which human foreskin-
derived neonatal epidermal keratinocytes are then cultured and allowed to stratify 
[99]. Others commercially available skin substitutes are presented in Table 1. 
Table 1 Tissue-engineered skin substitutes. Adapted from [87] 
 
58 
 
These models shown success in clinical trials and are used in the clinic. However, 
they are still fraught of limitations. Sometimes patients have to undergo multiples 
surgical interventions because of the impossibility to transplant full-thickness 
construct owing the difficulty of diffusion of nutrients in thick tissues before host 
vessels invasion and vascularization. Moreover some of these models are very 
fragile, deformable, not able to withstand shear forces in vivo and hardly handled 
by surgeons [95].  
 Skin models for in vitro applications 
Besides the use of skin models as in vivo grafts, as, recently, other applications 
have emerged for skin substitutes as in vitro test systems. In this context, they 
enable not only the investigation of fundamental processes in the skin, but also the 
hazard assessment of various chemical compounds that are topically applied on the 
skin without the need to use animal models which can present significant 
differences with humans and whose use has been limited by ethical guidelines 
[100]. For several years, two dimensional (2D) in vitro monolayer cultures of 
human cells were use but these platforms are low relevance due to the lack of 
complex cell–cell and cell–ECM interactions [101]. To date, many types of skin 
substitutes, with or without a dermal component, have been developed and 
commercially available by different groups. Some of these were already developed 
in the early 1990’s including the EpiSkin™ model (L’Oréal, Lyon, France) and 
EpiDerm™ model (MatTek Corporation, MA, USA). Subsequently, additional 
human skin models were introduced to the commercial market, including the RHE 
or Reconstructed Human Epidermis (SkinEthic, Lyon, France), the EST1000® skin 
model (CellSystems, Troisdorf, Germany), the Phenion® Full-Thickness Skin 
Model and OS-REp (Open Source Reconstructed Epidermis) model (Henkel, 
Düsseldorf, Germany), the Straticell model (Straticell, Les Isnes, Belgium), the 
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StrataTest® model (Stratatech, Madison, WI, USA) and the more recently 
introduced Labcyte model (Gamagori, Japan) and Vitrolife-Skin™ model (Kyoto, 
Japan ) [102]. Mainly models are described in Table 2. 
Table 2 Commercially available in vitro epidermal and full-thickness skin substitutes. Adapted from [94] 
 
 Vascularized skin equivalent models 
Several studies show that endothelial cells within a 3D matrix, in presence of 
fibroblasts, are able to sprout and develop a capillary network. After graft, 
capillaries of pre-vascularized constructs are able to anastomose with host vessels 
at the site of implant [1]. Anastomosis of the pre-vascularized constructs requires 
about 4 days while the de novo vascularization of not vascularized skin/dermis 
substitutes occurs in approximately 2 weeks (Fig.4) [103]. Thus, ensuring adequate 
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oxygen and nutrients supply to all the cells of the construct in a relatively short 
time. This is very important in case of full thickness skin graft and it allow to solve 
some important limits of classical skin substitutes. 
 
Fig. 4 Different times of neovascularization and inosculation. Neovascularization requires the migration 
of new blood vessels originating from the wound bed by angiogenesis and it is a slow process, which 
depends on the graft thickness. Inosculation is the connection of the blood vessel-like network of the 
graft with the host’s vasculature. It is a rapid process (less than 4 days) and should be independent of the 
graft thickness. 
The first vascularized skin-equivalent model in vitro is to Auger et al in 1998. The 
tissue was obtained through a co-culture of three types of human cells: fibroblasts, 
endothelial and epithelial cells within chitosan / collagen scaffolds. In the skin-
equivalent model endothelial cells are capable of spontaneously forming, after 31 
days, capillary structures in a highly differentiated extracellular matrix showing 
positivity for von Willebrand factor, the bodies of Weibel-Palade, the Laminin and 
Collagen IV, typical of the microcirculation in vivo vessels [10]. Endothelial cells 
were Human Umbilical Vein Endothelial Cells (HUVECs). Another work show 
that HUVECs can also grow and differentiate within artificial dermis obtained by 
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seeding fibroblasts on scaffold of hyaluronic acid and the best ratio for the co-
culture, in terms of viability and metabolic activity, is of 1: 1 [18]. 
Besides HUVECs, several works demonstrated the ability of primary human 
dermal microvascular endothelial cells (HDMECs) to form capillary like structures 
both in presence or in absence of fibroblasts [104]. Pouliot et al developed a 
vascularized skin substitute the self-assembly method. They seeded HDMECs on 
fibroblasts sheets obtained culturing fibroblasts with ascorbic acid for 3 weeks in 
order to produce collagen. Endothelialized fibroblasts sheets were overlapped and 
cultured for 1 week as vascularized dermis on which Keratinocytes were seeded for 
the development of the vascularized skin model (Fig.5).  
 
Fig. 5 Self-assembly method and experimental timelines [105]. 
They showed that the epidermal component of the substitutes can promote network 
expansion and density in the right culture condition [105]. 
62 
 
Recent studies show that HDMECs can develop both blood and lymphatic vessels 
in vitro. Reichmann et al used a co-culture of endothelial cells and fibroblasts in 
hydrogel of pressed collagen I or fibrin. They cultured HDMECs from foreskin 
biopsies which include a mixed population of endothelial cells of both blood and 
lymph. After 3 weeks of 3D in vitro co-culture HDMECs organize themselves into 
blood and lymphatic capillaries structures as demonstrated by the positivity for 
CD31 marker (pan-endothelial) and Prox-1/Lyve-1 and podoplanin (lymphatic 
marker). Lymphatic vessels, unlike blood 
ones, possessed incomplete or absent 
basement membrane and lack of mural 
cells. Interestingly, the blood vessels and 
the lymphatic never anastomosed between 
them in vitro (Fig.6). 
Keratinocytes were seeded on the surface of 
this vascularized dermis model after 2 
weeks of HDMECs and fibroblasts co-
culture. After another week, the complete 
model was transplanted on the back of nu / 
nu immunosuppressed rats. 2 weeks after 
implantation the tissue was surgically removed and subjected to analysis which 
showed the successful anastomosis between the lymphatic vessels of the construct 
with the host ones as well as for blood vessels. In addition, the functionality of 
lymphatic vessels was evaluated by Evans Blue dye injection. The study showed 
that the hydrogel containing only the fibroblasts (negative control) restrained a five 
times higher amount of dye than the sample with lymphatic capillary network 
indicating the effective drainage function [4]. 
Besides the development of vascularized skin models for in vivo applications, 
several works underline the importance of vascularized models for drug screening. 
Fig. 6 CD31 in red shows all the endothelial 
cells. Prox1 in green mark the nuclei of 
lymphatic cells. Blood and lymph vessels don’t 
anastomose between them in vitro. Scale bar 
50µm [4]. 
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In fact these complex models can be used for the study of molecules or active 
principles such as anti-inflammatory, pro/anti- angiogenic acting via topical or 
systemic administration [1]. Some works suggest innovative techniques for in vitro 
blood vessels perfusion which could be recapitulated for the development of 
perfusable vascularized skin models.  
Okano et al overlaid triple layer of cardiac cell sheets, co-cultured with endothelial 
cells, on a resected tissue with a connectable artery and vein as vascular bed. The 
construct was supported by media perfused in a bioreactor. They showed that 
endothelial cells were able to connect to capillaries in the vascular bed and form 
tubular lumens, creating in vitro perfusable blood vessels in the cardiac cell sheets. 
Thicker engineered tissues can be produced in vitro by overlaying additional triple 
layer cell sheets (Fig.7) [106]. 
 
Fig. 7 In vitro engineering of functional 3-D tissue with perfusable blood vessels [22]. 
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George et al combined tissue engineering and microfluidic technology to create an 
in vitro 3D metabolically active containing a perfused, living, dynamic, 
interconnected human capillary network. The platform is constructed using 
standard photolithography from polydimethylsiloxane siloxane (PDMS) and 
consists of two outer microfluidic channels that act as arteriole (high pressure) and 
venule (low pressure), connected by three tissue chambers, into which is injected a 
slurry of fibrin, fibroblasts and endothelial cells. Over the course of 5–7 days 
endothelial cells self-assemble into an interconnected network that anastomoses 
with the outer channels [77]. Endothelial cells were able to migrate into the outer 
channels, forming a tight seal, and over time, line the surface of the channel. At this 
point flow through the device switched from interstitial to intraluminal [76] (Fig.8).  
 
Fig. 8 Microfluidic platform for the development of a perfused capillary network. Endothelial cells are 
seeded within a fibroblast rich fibrin matrix into chambers connected to fluidic channels by pores. 
Endothelial cells ( marked in green by CD31) are able to anastomose with l channels [77]. 
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Chapter 3 
 
 
 
Heterogeneous invasive tumor 
mammary model featured by 
vascular and desmoplastic reaction 
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3 Abstract 
Breast cancer is one of the most common cancers and the most frequent cause of 
mortality in patients is metastasis. Today researchers are still looking for new 
strategies of treatment. Difficulties arise from lack of an effective model able to 
recapitulate tumor heterogeneity and microenvironment. This is a complex milieu 
in which cancer cells and non-cancer cells are in mutual interaction into an 
activated stroma. The increase in pro-angiogenic signals by tumor cells induces the 
formation of a discontinuous and intricate vascular network with mosaic wall and 
variation in vessel diameter. Capillary density correlates positively with tumor 
malignancy. The activation of stromal cells by cancer cells induces the 
desmoplastic reaction with the increase in dense and aligned collagen and other 
molecules of the connective tissue such as hyaluronic acid. The entity of the 
desmoplastic reaction correlates positively with tumor invasiveness. Cancer cells 
during metastasis move across the ECM toward blood and lymphatic vessels 
adopting different shapes in order to stay always motile. Here we show a new 
breast cancer model able to recapitulate these critical features of tumor 
microenvironment and metastasis. We develop MCF7-µTPs in which pro-
angiogenic signals lead the increase in capillary-like structures (CLS) volume 
fraction, n° of junctions/µm
3
 and vessel diameter which wall is a mosaic of tumor 
and endothelial cells. The desmoplastic reaction occurs in the model with increase 
in collagen fraction, assembly and correlation and decrease in entropy. The model 
reiterates also the different morphologies of tumor cluster migration into the ECM 
recapitulating tumor heterogeneity in space and time. We speculate that MCF7-
µTPs are suitable composite models for the study of tumor progression into an 
activated microenvironment and for drug screening assays. 
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3.1 Introduction 
Breast cancer is one of the most common cancer in woman [25]. The most frequent 
breast cancer is the invasive ductal carcinoma (IDC) which starts in the epithelial 
cells lining the ducts of the mammary gland and invade the breast tissue moving 
toward blood or lymphatic vessels [26]. Metastasis is a hallmark of breast cancer 
leading cause of mortality among patients [49]. 
Despite significant improvements in cancer field, researchers are still working to 
find new and effective therapies against tumor. Part of the issue is the lack of 
suitable preclinical models able to recapitulate the complexity of cancer disease 
[29]. It is not only a pathology interesting neoplastic cells but the entire 
environment in which they are and move and with which they active interact by 
direct and indirect signals [31] .Tumor microenvironment is a complex milieu 
comprising cancer and non-cancer cells embedded into the ECM [32]. Cancer cells 
are mainly epithelial cells, while non-cancer cells are inflammatory/immune cells, 
vascular cells and stromal cells (e.g. fibroblasts). The interstitial matrix of the ECM 
consists of fibrillary collagens, proteoglycans and glycoproteins [33]. All these 
elements of the microenvironments are influenced by cancer cells and in turn 
influence tumor genesis and progression [35] [46]. So, in order to understand tumor 
growth and to develop new therapies it needs to consider all the components of 
tumor environment [31]. 
In particular, model of invasive breast cancer must take into account the 
fundamental role of tumor angiogenesis [36] and of the desmoplastic stromal 
reaction [46] which are key elements for metastatic events. 
It was demonstrated that without blood vessels, tumors cannot grow beyond a 
critical size (1-2mm in diameter) or metastasize to other organs [36]. In this case 
tumors enter a dormant though viable state until they are able to secrete angiogenic 
factors and downregulate angiogenic suppressors [37]. Cancers recruit new blood 
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vessels by vasculogenesis and angiogenesis, by activating the so called ‘angiogenic 
switch’ that impairs the balance between pro and anti-angiogenic factors in favor of 
the pro-angiogenic ones [34]. The overall vascular density in tumors is increased 
but, nevertheless blood vessels are abundant in certain regions of the tissue, there 
are also some zones of ischemia and necrosis [39]. The vascular architecture has 
abnormal features such as thin walls, tortuous shape, absence of pericytes and 
variation in diameter. Numerous gaps or fenestrae are found between endothelial 
cells and the vessel wall is like a mosaic consisting of both endothelial and tumor 
cells [40] The desmoplastic reaction is characterized by amplified collagen 
deposition and stromal cells recruitment and activation (e.g. fibroblasts, 
macrophages) [45]. It consists in the increase in dense and fibrotic connective 
tissue rich in collagen and other ECM molecules such as hyaluronic acid, 
surrounding the tumor mass. The role of the desmoplastic reaction is object of 
interesting studies and it has been proposed as phenomenon induced by cancer cells 
to assist their propagation [48]. In fact it was demonstrated that the presence of a 
dense and aligned collagen enhances mammary tumor invasion and metastasis [45] 
[46]. The first step of tumor metastasis is the migration into the interstitial matrix 
toward blood or lymphatic vessels. Cells can move as single cells or in cluster 
(collective migration). They possess a unique ability to adapt to different 
environmental conditions, assuming different morphologies and migration 
characteristics in order to stay motile. In human cancer pathology studies, cancer 
cells from epithelial tumors primarily invade collectively. In intravital imaging 
studies, cancer cells display a wide range of different migration modes which are 
determined by both intrinsic factors and the microenvironment [49]. Friedl and 
Alexander talk about cancer cell invasion like a heterogeneous and adaptive 
process in which “plasticity” in cell adhesion, cytoskeletal dynamics, and 
mechanotransduction perpetuate migration and dissemination under diverse 
structural, molecular, and even adverse microenvironmental conditions, thus 
69 
 
inducing tumor cells resistance [51]. After interstitial invasion, tumor cells cross 
the discontinuous endothelial wall and enter the bloodstream. Here they circulate as 
single cells or clusters [56] [57] toward secondary sites of metastasis [53]. All of 
these analyzed elements, namely tumor angiogenesis, tumor desmoplastic reaction, 
tumor migration and invasion, could be target of cancer therapies because annoying 
each of them, the entire equilibrium leading tumor progression and metastasis 
could be altered. 
Because in vivo animal model often fail to represent the pathology of human 
tumors, several in vitro models have been developed [32]. Whereas 2D cell cultures 
are not able to replicate the in vivo phenotype, which is strongly influenced by the 
microenvironment, there have been promising published works on 3D cell culture 
models [29] [62]. Bissels and Nelson have been one of the pioneers to use 3D to 
model the murine gland in both its normal and diseased state [63]. In vitro 3D 
breast cancer model include cells cultured as multicellular aggregates (spheroids) 
and cells embedded into natural (such as Matrigel, Fibrin or Collagen) or synthetic 
matrices (such as PLG, PLA, PEG) generally cultured in multiwell or into 
microfluidic devices [29]. Although these models have been used for the study of 
breast cancer and development of drugs, none of them recapitulates the actual 
environment in which cancer cells are found in vivo. In fact spheroids are 
characterized by shortage of collagen [65] and natural or synthetic matrices do not 
represent the complexity of the microenvironment typically associated with 
advanced carcinoma in vivo. Another recent culture system involve cell seeding on 
fibroblasts 3D matrices but these are commonly murine [79] [80] [81]. This could 
be a limit for the study of desmoplastic events which seems to be nearly an 
exclusively human occurrence, being quite rare among spontaneous and 
transplantable animal tumors and absent in most human tumoral xenografts in 
athymic nude mice [47].  
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In vitro models have the potential to explore mechanistically the individual 
contributions of various components of the microenvironment on tumor cell 
behavior, and the ability to modulate the biophysical and biomechanical aspects but 
they cannot recapitulate every aspect of the tumor microenvironment. For example, 
while a 3D culture of tumor cells in a collagen gel under interstitial flow might be 
used to explore direct effects of interstitial flow on tumor cell invasion it ignores 
other factors present at an invasive edge of the tumor such as the architecture and 
composition of the ECM (which is highly heterogeneous), the diversity of cell 
types present in the tumor stroma and their interaction [107]. 
Moreover, nevertheless cancer cell invasion is described as a heterogeneous and 
adaptive process [51], most of the 3D in vitro models fail to reproduce tumor 
complexity and plasticity, because they use homogeneous and passive scaffold [70] 
whose properties cannot be altered easily to interrogate the contributions of specific 
environmental cues to tumor assembly [71].  
Here we present MCF7-µTP as new invasive breast cancer model featured by 
vascular and stromal reaction and able to recapitulate tumor cells plasticity and 
heterogeneity into an active microenvironment. MCF7 seeded on mammary HDFs-
µTPs are able to induce the increase of the angiogenesis and the activation of the 
desmoplastic stromal reaction. Cluster of tumor cells take different morphologies 
of migration into the stroma recapitulating the heterogeneous shapes of collective 
interstitial invasion. The model replay the phenomenon of mosaic vessel formation 
by metastatic and endothelial cells which could be a preliminary state of tumor 
cluster shed into the circulation for aggressive metastasis [60].  
Moreover, in several works MCF7 have been described as a tumor cell line without 
pro angiogenic potential and low invasive [72] [108] [109], while being a breast 
cancer cell line from pleural effusion. Interestingly, here we show that MCF7 into a 
human mammary fibroblast assembled collagen, are able to show pro angiogenic 
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and invasive features, underlining the fundamental role of the right in vitro 
microenvironment in the determination of cell phenotype [67].  
Because MCF7-µTPs are representative of crucial events featuring tumor 
progression in vivo and they are easy to produce and in large quantity, we speculate 
that they depict a suitable model for drug screening. 
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3.2 Materials and Methods 
3.2.1 Cell culture 
Human dermal fibroblasts (HDFs) were extracted from healthy breast biopsies 
(protocol described in Chapter 5) and cultured in enriched MEM: MEM (Microtech 
L0440-500) with 20% of FBS (Sigma Aldrich F7524), 2% of Non-Essential 
Aminoacids (EuroClone ECB3054D), 1% of L-Glutamine (Lonza 17-605E) and 
1% of penicillin/streptomycin (Microtech L0022-100), until passage 4/7.  
HUVECs (GIBCO C0035C) were cultured in enriched M200: M200 (GIBCO 
Invitrogen Cell Culture M-200-500) supplemented with LSGS Kit (GIBCO 
Invitrogen Cell Culture S-003-K) until passage 3. 
Human breast adenocarcinoma cells (MCF7) were kindly donated by Daidone's 
group (IRCCS, Istituto Nazionale dei Tumori, Milano, Italy) and cultured in 
enriched RPMI: RPMI-1640 (Microtech) medium supplemented with 10% FBS, 
1% L-glutamine, 1% penicillin / streptomycin. MCF7 cells were transfected with 
pLVX-ZsGreen1-N1 (λex 493nm, λem 505 nm) viral vector purchased from 
Clontech, USA.  
Human non-tumorigenic epithelial cell lines MCF10 (ATCC CRL-10317) were 
cultured in enriched MEBM: MEGM BulletKit (Lonza CC-3151 & CC-4136). 
Cells were maintained at 37 °C in humidified atmosphere containing 5% CO2. 
3.2.2 Micro-scaffold production 
Gelatin porous microbeads (GPMs) were prepared according to a modified double 
emulsion protocol (O/W/O) [110]. GPMs were stabilized by crosslink reaction with 
glyceraldehyde (GAL) (SIGMA-G5001), in order to make them stable in aqueous 
environment at 37 °C, as previously described [94]. GAL at 4% w/w of the 
microbeads was used to perform all the experiments. 
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3.2.3 Micro-tissues production 
All cells were cultured into spinner flask bioreactor (Integra) in continuous 
agitation (30 rpm) after 6 hours of intermitting stirring regime in order to promote 
cell seeding (30 min at 0 rpm, 5 min at 30 rpm). 
Firstly 3,5*10
6
 HDFs P5/8 were seeded on 64mg of porous gelatin microspheres in 
order to have about 11 cells for bead. The culture medium was enriched MEM plus 
Ascorbic Acid (2-O-α-D-Glucopyranosiyl-L-Ascorbic-Acid TCI; Cf: 0.5mM). 
After 7-9 days 1*10
6 
HUVECs were seeded on HDFs micro-tissues (HDFs μTPs). 
Specifically, about 500 cells were seeded for μTP into spinner flask in agitation and 
cultured in a medium composed by 1/3 of enriched M200 and 2/3 of enriched 
MEM plus Ascorbic Acid, in order to obtain vascularized HDFs μTPs. After 7-9 
days of culture μTPs were splitted from 1 to 3 spinner flasks and 7*106 MCF10 and 
MCF7 were seeded separately into 2 bioreactors to produce MCF10-μTPs and 
MCF7-μTPs. About 30.000 epithelial cells (MCF10 or MCF7) were seeded for 
μTP. The media used for the tri-culture were: 1/3 of enriched MEM + 1/3 of 
enriched M200 + 1/3 of enriched MEBM plus Ascorbic Acid for MCF10-μTPs and 
1/3 of enriched MEM + 1/3 of enriched M200 + 1/3 of enriched RPMI plus 
Ascorbic Acid for MCF7-μTPs. The third spinner flask without epithelial cells was 
used as control (CTRL) and cultured in a medium with 1/3 of enriched M200 and 
2/3 of enriched MEM plus Ascorbic Acid. Cells were cultured for 10 days into 
spinner flask in agitation. Samples were harvested 6 hours, 3 and 10 days after the 
seeding of MCF10 and MCF7. 
3.2.4 Histological analysis 
Samples were fixed in Formalin 10% (HT501320 Sigma) for 1h at Room 
Temperature (RT) and washed in PBS1X (P4417-100TAB Sigma). They were 
dehydrated in Ethanol from 75% to 100% and treated with Xylene (A9982 
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ROMIL) before the inclusion in Paraffin. Tissue slices thick 7µm were cut using a 
microtome (Thermo Scientific HM 355S) and then deparaffinized using xylene. 
Sections were hydrated in ethanol from 100% to 75%, washed in water and stained 
using Masson’s trichrome (HT15-1KT Sigma-Aldrich) in order to distinguish cell 
cytoplasm and muscle fibers in pink to red thanks to fucsin, collagen in blue thanks 
to anilin and nuclei in dark brown to black thanks to hematoxylin. The sections 
were mounted with Histomount Mounting Solution (Bio Mount HM 05-BMHM500 
Bio-Optica) on coverslips and the morphological features of μTPs were observed 
with a light microscope (Olympus, BX53). 
3.2.5 Immunofluorescence analysis 
 Immunofluorescence on the whole sample 
Sample were fixed in 4% Paraformaldehyde (P61148-500g Sigma Aldrich) for 30’ 
at RT and washed in PBS1X. They were permeabilized using 0,1% Triton (Triton® 
X-100 T9284-100ML Sigma) in PBS1X for 5’ at RT, washed in PBS1X and 
blocked in 3%BSA (A9418-100G Sigma), 3%FBS (F7524 Sigma), 0,01%Triton in 
PBS1X for 1h at RT. For the detection of the epithelial cells MCF10- μTPs were 
incubated in presence of the primary antibody against K14 (PRB-155P-100 
Covance, Rabbit Polyclonal) diluted 1:300 in blocking solution. All the μTPs 
(CTRL, MCF10-μTPs and MCF7-μTPs) were stained with Rhodamine Ulex 
Europaeus Agglutinin I (UEAI Vector Laboratories RL-1062) at a final 
concentration of 20μg/ml in blocking solution in order to mark the endothelium. 
Samples were left in the solution with the antibodies overnight (ON) at 4°C in the 
dark. The morning after a Goat Anti-Rabbit IgG (H+L) Secondary Antibody Alexa 
Fluor 488 (A11008 diluted 1:500 in PBS1X), was used in order to mark K14 on 
MCF10- μTPs for 1h and half at RT. The nuclei of all the cells were stained with 
4’,6-diamidino-2-phenylindole (DAPI Sigma-Aldrich D9542) diluted 1:10.000 in 
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PBS1X for 20’ at RT. Samples were investigated by Confocal Leica TCS SP5 II. 
Images and z stack were analyzed using Image J. 
 Immunofluorescence on tissue sections 
Samples were fixed in Formalin 10% (HT501320 Sigma) for 1h at Room 
Temperature (RT) and washed in PBS1X (P4417-100TAB Sigma). They were 
dehydrated in Ethanol from 75% to 100% and treated with Xylene (A9982 
ROMIL) before the inclusion in Paraffin. Tissue slices thick 7µm were cut using a 
microtome (Thermo Scientific HM 355S) and then deparaffinized using xylene. 
The sections were hydrated in ethanol from 100% to 75% and washed in water, 
Triton 0,2% and PBS1X. In order to release the epitopes from paraffin, heat 
mediated citrate buffer (pH=6, Thermo scientific TA-125-PM1X) unmasking was 
performed before the immunofluorence for keratin 14 (K14), whereas for K14 and 
hyaluronic acid an enzymatic unmasking was performed rinsing the slices in a 
solution with CaCl2 (1.02378.0500 Merck) and Trypsin (215240 Difco
TM 
Trypsin
 
250) at a final concentration of 0,01% in PBS1X (pH 7.8) for 20’ at 37°C. Sections 
were washed in PBS1X and blocked using BSA6%, FBS 5%, MgCl2 20Mm and 
Tween20 0,02% in PBS1X for 2h at RT. Primary antibodies were diluted in 
blocking solution and they were: anti-Hyaluronic acid polyclonal antibody (dilution 
1:50, Abcam ab53842) and anti-Keratin 14 polyclonal antibody (dilution 1:500, 
Covance PRB-155P). Sections were incubated with the primary antibodies ON at 
4°C in a wet environment. The morning after samples were washed in PBS1X and 
the secondary antibodies 546 Donkey Anti-Sheep IgG H&L (dilution 1:500, Alexa 
Fluor® 546 A21098) and Goat Anti-Rabbit IgG (H+L) Secondary Antibody Alexa 
Fluor 488 (1:500, A11008) in PBS1X were added for 1h and half at RT. Nuclei 
were stained with DAPI and samples were investigated by Confocal Leica TCS 
SP5 II.  
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3.2.6 Quantitative MCF7 analysis 
After immunofluorescence, whole samples and tissue sections were investigated by 
Confocal Leica TCS SP5 II performing at least 21 images in different random 
points of different μTPs. Samples were observed using λex = 488 nm/ 
λem=500/530 nm to detect Rhodamine and λex=700 nm (two photons)/ 
λem=400/450 nm to detect DAPI. Images were acquired with a resolution of 12 bit, 
512x512 pixels by using a 25X water immersion objective (HCX IRAPO L 
25.0X0.95 Water, n.a. 0.95). For each image (acquired unit) the number of 
MCF10/MCF7 was manually counted. 
3.2.7 Quantitative Capillary-like structures (CLS) analysis 
Whole samples were investigated by Confocal Leica TCS SP5 II performing 5 z-
stacks in different random points of different μTPs. Samples were observed using 
λex = 543 nm/ λem=550/560 nm to detect Rhodamine and λex=700 nm (two 
photons)/ λem=400/450 nm to detect DAPI. The stacks were acquired with a 
resolution of 12 bit, 512x512 pixels by using a 25X water immersion objective 
(HCX IRAPO L 25.0X0.95 Water, n.a. 0.95). Each stack was composed by 16 
sequential images with a z-slice-space of 1,98 µm. 
 CLS volume fraction 
The capillary like structures (CLS) volume fraction was calculated as percentage of 
the ratio between the thresholded red volume of the endothelium marked by 
Rhodamine-UEAI and the total volume of the sample acquired for each stack. The 
volume values were obtained applying the ImageJ plugin Measure Stack to the red 
thresholded channel and on the total µTP acquired volume. 
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CLS Volume fraction =
acquired CLS volume
acquired sample volume
∗ 100 
 Analysis of the junctions 
The number of junctions for each stack was calculated using the plugin Skeletonize 
3D of ImageJ. Before the analysis, the red channel of the stacks was thresholded 
and smoothed in order to avoid the identification of false positive junctions by the 
plugin. The number of junctions for μm3 was calculated as ratio between the 
number of junctions for stack and the total acquired volume obtained by Measure 
Stack. 
 
Junctions/μm3 =
n° of junctions for stack
acquired sample volume
 
 CLS diameter analysis 
The diameter of the capillary like structures was calculated tracing at least 3 
adjacent lines joining the opposite major sides of capillaries using ImageJ. For each 
sample the diameter was calculated at least three times for each image of the z 
stack and then the mean and the standard deviation were represented in the graphic.  
3.2.8 Second harmonic generation signal (SHG) 
For SHG imaging samples were investigated by confocal microscopy (TCS SP5 II 
Leica) combined with a MPM where the NIR femtosecond laser beam was derived 
from a tunable compact mode-locked titanium: sapphire laser (Chamaleon 
Compact OPO-Vis, Coherent). Two-photon excited fluorescence was used to 
induce SHG and obtain high-resolution images of unstained collagen structures. 
The samples were observed by using λex = 840 nm (two photons) and λem=415-
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425 nm. The SHG images were acquired with a resolution of 12 bit, 512x512 pixel 
by using a 25X water immersion objective (HCX IRAPO L 25.0X0.95 Water, n.a. 
0.95). 
3.2.9 Quantitative matrix analysis 
 Gray-level co-occurrence matrix analysis: Correlation and entropy 
To quantitatively assess the collagen-related changes, gray-level co-occurrence 
matrix (GLCM) texture analysis was performed using the ImageJ plugin Texture 
on SHG as previously described by Walker and collaborators [111]. The features 
correlation and entropy were evaluated. The correlation of the images reflects the 
similarity on a direction of the image texture area and it is the linear correlation 
measure of the local gray level in the image. This correlation is a measure of the 
dependence between two different pixel values. In particular, the correlation feature 
indicates a relation of intensity measure as a function of pixel distance, which is 
used to assess the similarity of matrix pixel horizontally and vertically. Entropy is 
the complexity feature of an image matrix and it mainly reflects the texture 
grayscale randomness distribution of the image. When the image has many fine 
textures the value of entropy is larger, and vice versa when the image has less 
number of fine textures the entropy value is smaller [112]. Here the correlation and 
entropy curves were calculated for distances ranging from 1 to 100 pixels in the 
horizontal and vertical direction of each optical section. In such spatial windows 
the distance at which the correlation functions fall off represents the correlation 
length of the texture. Correlation length was obtained by fitting data with an 
exponential low [113] [114].  
 
79 
 
 Collagen amount quantification 
SHG images were analyzed using ImageJ software. Image from each z-stack were 
thresholded and for each one at least 3 ROIs of the same dimension were chosen in 
order to avoid the beads signal. The selected areas were analyzed by measuring the 
percentage of the ratio between the black pixels representative of the gray collagen 
signal respect to the total pixels. The % area was calculated by the software. The 
final value was calculated as mean of the % area of each ROI selected for sample 
and time. 
 Collagen assembly degree 
SHG images were analyzed by using ImageJ software. The degree of Collagen 
assembly degree (CAD) was evaluated by analyzing the Histogram of the SHG 
images in order to calculate the average intensity, as described by the equation: 
𝐶𝐴𝐷 =
∑ 𝐼𝑖𝑝𝑖255𝑖=1
∑ 𝑝𝑖255𝑖=1
 
Where I is the average intensity and Ii is the intensity corresponding to the pixel pi, 
which runs in the gray value interval from 1 to 255. The intensity I of collagen 
network is known to be proportional to the degree of assembly of the newly 
synthesized collagen. 
 Hyaluronic Acid quantification  
The fluorescent images were analyzed for semi-quantitative evaluation with 
ImageJ. After threshold, the RED area relative to hyaluronic acid was divided by 
the total number of cells obtained by analyzing the blue channel of DAPI with 
Analyze particle. 
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 Collagen fibers and tumor clusters orientation 
Collagen fibers orientations were calculated by using the plugin OrientationJ of 
ImageJ. The plugin evaluates the local orientation and isotropic properties 
(coherency and energy) of every pixel of the image [115]. We specified the 
following parameters: Gaussian window σ 1 pixel, Min Coherency 20%, Min 
Energy 2%. The plugin outputs a hue-saturation-brightness (HSB) color-coded map 
which shows the angles of the oriented structures in the image, i.e. turquoise 
corresponds to 0° and red corresponds to ±90° [115]. The plugin also outputs a 
distribution of the fibers alignment directions. These distributions were normalized 
in order to obtain a normal distribution and compare fibers alignment in different 
point of the same sample. 
Tumor orientation in degree was calculated by using Orientationj Measure on 
selected ROI around each cluster. 
3.2.10 Statistics 
Experiments were performed in triplicate. Data are expressed as mean ± SD. 
Differences between groups were determined using the statistic test ANOVA 
Tukey HSD test. Significance between groups was established for p value<0.01 or 
p value<0,05. 
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3.3 Results 
3.3.1 Development of vascularized tumor µTPs 
In this work, metastatic breast cancer cells (MCF7) and breast epithelial non-
tumorigenic cells (MCF10) were seeded on vascularized HDFs-µTPs in order to 
obtain MCF7-µTPs and MCF10-µTPs.  
Vascularized HDFs-µTPs were obtained seeding endothelial cells on HDFs-µTPs. 
HUVECs were able to seed and spread into HDFs-µTPs forming capillary-like 
structures (CLS) into the collagen rich matrix produced by mammary fibroblasts. 
CLS were growing up to 28 days after seeding without morphological signs of 
regression (Fig.1). Vascularized HDFs-µTPs were used as control (CTRL) in this 
work. 
 
 
Fig. 1 Vascularized HDF-µTPs: In green the nuclei of all the cells marked by Sytox green; in red the 
HUVECs marked by UEAI and in gray the second harmonic generation signal of collagen. The endothelia cells 
start to spread from day 3 after seeding and form CLSs growing up until 28 days after seeding without 
morphological signs of regression. Dimensional bar: 75µm. 
MCF7 and MCF10 arranged themselves differently once seeded on vascularized 
HDFs-µTPs. MCF10 adhered on the surface of the samples and then entered the 
matrix and localized around the perimeter of the beads. After 10 days, they 
polarized forming acinar structures as typical of exocrine glands like the mammary 
one.  
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MCF7 adhered on the surface of the sample and penetrated the matrix as well as 
MCF10 but they assumed heterogeneous morphologies in clusters. The number of 
cells for acquired unit was significantly increasing from the start to the end of the 
culture period for both MCF10 and MCF7. Nevertheless, the number of MCF7 was 
always greater than MCF10 excluding the time 6 hours that was the initial 
condition in which cells were seeded in equal number. From the image analysis of 
the number of cells for acquired unit, it is possible deduce that the proliferation rate 
of MCF7 was faster than MCF0 as expected by tumoral vs non-tumoral cells 
(Fig.2). 
 
 
Fig. 2: Non-tumoral vs tumoral cells organization and proliferation: A+B) MCF10 are marked in green by 
indirect immunofluorescence for K14. The MCF7 are ZsGreen1+. The nuclei of all the cells are marked in blue 
by DAPI. Scale bar 100 µm; B) the HUVECs are marked in red by UEAI. MCF10 preferentially localize 
around the surface of the sample, around the beads and forming acinar structure. MCF7 form irregular cluster 
on the surface of the sample and into the matrix. Scale bar in B: 75 µm. C) Graphic of the number of cells per 
acquired unit. * p value< 0.05. 
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3.3.2 Tumor increases angiogenesis in the tissue model 
 CLS volume fraction and n° of junctions/µm3 
The z-stacks analysis of acquired samples volumes demonstrated that tumor cells 
were able to secrete pro-angiogenic stimuli as indicated by the increase in CLS 
volume fraction and in the number of junctions/µm
3
. The images and graphics 
show the CLS volume fraction and the number of junctions/µm
3
 of MCF7-µTPs 
compared with MCF10-µTPs and vascularized HDFs-µTPs, used as control 
(CTRL). Both parameters were increasing for all three types of tissues from 3 to 10 
days of culture but MCF7-µTPs values were always higher than the others, 
especially 10 days after seeding (Fig.3).  
 
Fig. 3 Tumor increases CLS volume fraction and of the number of junctions/µm3: A) in blue the nuclei of 
all the cells marked by DAPI, in red the HUVEC marked by UEAI, in green the MCF10/MCF7 marked by K14 
and ZsGreen1 respectively. Scale bar 100µm; B+C) Graphics of the CLS volume fraction and of the number of 
junctions/µm3. * p value< 0.05 
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 CLS diameter 
The CLS average diameter was compared among CTRL, MCF10-µTPs and MCF7-
µTPs. Data show that CLS average diameter was significantly higher for MCF7-
µTPs both 3 and 10 days after seeding. From 3 to 10 days the average diameter 
dimension remained almost unchanged for all three types of tissues (Fig.4). 
 
Fig. 4 Tumor increases capillaries diameters dimension: A) CLS marked in red by UEAI, the yellow lines 
connecting the two major sides of capillaries represents some of the length used for the image analysis. Scale 
bar 75 µm; B) Graphics of the diameter lengths. * p value< 0.05. 
 Close tumor vessels interactions 
We found a very fine interaction between tumor and capillary structures into 
MCF7-µTPs. 
Frequently tumor clusters were localized as files of multiple or single cells parallel 
aligned to CLS. The morphology of tumor cells in single file remind that featuring 
cluster of circulating tumor cells in capillaries [58] but outside vessels (Fig.5 A/B)  
3D views show a direct contact between MCF7 and HUVECs which together 
formed a tangled tumor mass surrounded and crossed by a discontinuous vascular 
network (Fig.5 C). In some cases, the interaction was so close to induce the 
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formation of mosaic vessels in which endothelial and tumor cells alternated in the 
capillary wall (Fig.5 D/E). 
 
Fig. 5 Tumor cells guide and follow CLS: A/B/C/D/E) In red the HUVECs marked by UEAI, in green MCF7 
ZsGreen1+. A/B) tumor clusters align parallel to CLS forming files of multiple or single cells. Scale bar on the 
left 100µm. Scale bar on the right 75µm; C) Tumor cells in close contact with the endothelium; D/E) Mosaic 
vessels. Scale bar 75µm. 
3.3.3 Desmoplastic stromal reaction 
 Quantitative collagen analysis 
Thanks to multiphoton technology and second harmonic generation signal (SHG) 
we acquired collagen images from vascularized HDFs-µTPs (CTRL), MCF10-
µTPs and MCF7-µTPs (Fig.6A).  
Collagen fraction was increasing from 3 to 10 days after seeding and in particular, 
after 10 days, the tumor associated collagen fraction was significantly higher than 
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CTRL and MCF10-µTPs (Fig.6B). Also the collagen assembly degree was 
increasing from day 3 to day 10 for all three types of tissue but always higher in 
MCF7-µTPs (Fig.6C). The Gray-Level Co-Occurrence Matrix (GLCM) revealed 
that the normalized correlation curves of CTRL, MCF10-µTPs and MCF7-µTPs 
decreased almost together after 3 days. Otherwise, at day 10, the normalized 
correlation curve of tumor tissue decreased slower than the healthy and control and 
the correlation length was significantly higher (Fig.6 D/E/F). The curves of the 
collagen entropy show an inversion from day 3 to 10. In fact, after 3 days the curve 
of MCF7-µTPs was higher than MCF10-µTPs and CTRL. Whereas, after 10 days, 
the curve of MCF7-µTPs was lower than CTRL and MCF10-µTPs (Fig.6 G/H).  
 
Fig. 6 The tumor associated extracellular matrix recapitulates events of the desmoplastic reaction: A) In 
gray the SHG collagen signal, in red the HUVECs marked by UEAI and in green the MCF10/MCF7 marked by 
K14 and ZsGreen1. Scale bar 75 µm; B) Graphic of the collagen fraction %; C) Graphic of the collagen 
assembly degree; D/E/F) GLCM analysis of collagen fibers correlation; G/H) GLCM analysis of collagen 
Entropy (Red MCF7-µTPs, Pink MCF10-µTPs, Brown CTRL). * p value< 0.05. 
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 Quantitative Hyaluronic acid analysis 
The quantitative image analysis after indirect immunofluorescence revealed an 
increase in hyaluronic acid in tumor tissues compared to the control and healthy 
ones (Fig.7). This parameter is in accordance with the data about collagen 
confirming the activation of the stromal desmoplastic reaction after 10 days (Tab 1)  
 
 
Fig. 7 Increase in hyaluronic acid in tumor: Indirect immunofluorence for Hyaluronic acid in red. The nuclei 
of all the cells are marked in blue by DAPI, the MCF10 are marked in green by K14 and the MCF7 in green by 
ZsGreen1. Scale bar 75µm. The graphic is representative of the quantitative image analysis for hyaluronic acid 
in CTRL, MCF10-µTPs and MCF7-µTPs. * p value< 0.05.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 Summary of the desmoplastic reaction in and MCF7-µTPs 
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3.3.4 Spatiotemporal heterogeneity 
MCF7 seeded on the surface of µTPs were able 
to penetrate the collagen matrix (Fig.8). After 3 
days, tumor cells moved both as individual cells 
and clusters, whereas after 10 days they were 
only in the conformation of compact clusters 
(Fig.9). 
 
 
Fig. 9 MCF7 move as individual cells or clusters after 3 days and as compact clusters after 10 days: In 
green the MCF7 ZsGreen1+, in red the UEAI for endothelial cells detection and in gray the SHG signal of 
collagen. Up) 3D view of a tile scan and z stack on tumor tissue after 3 (on the left) and 10 (on the right) days. 
Down) images on tumor cells and cluster moving into the collagen matrix. Scale bar 75µm. 
On the external surface of MCF7-µTPs, tumor cells grew by expansive growth 
without physical confinement on proliferation (Fig.10A on the left). Both 3 and 10 
days after seeding, MCF7 clusters showed different morphologies. MCF7 invaded 
3 DAYS 10 DAYS 
Fig. 8: MCF7 penetrate the collagen matrix: 
Masson's trichrome of MCF7 µTPs after 10 
days. On the left MCF7 on the surface of the 
sample. On the right MCF7 clusters into the 
tissue matrix. Scale bar 50µm. 
89 
 
the tissue in form of single files, multicellular strands with a blunt extremity 
(protrusive strand) or with leader cells on a tip (solid strand) and round clusters 
(Fig.10A), appointed on the basis of literature [51]. These movements are typical of 
metastatic cells invading the matrix toward blood and lymphatic vessels. Single 
files of cells were often parallel to capillaries and multicellular strand with leader 
cells on a tip seemed to point endothelial structures.  
Tumor structures were simultaneously present in a single tissue and at different 
time points. Thus, demonstrating that MCF7-µTPs environment preserved 
spatiotemporal tumor heterogeneity. The number of cells for cluster was 
significantly increasing from 3 to 10 days, revealing that tumor cells in cluster were 
able to perpetuate their differences while proliferating (Fig.10B). 
 
Fig. 10 MCF7-µTPs recapitulate tumor heterogeneity: A) In green the MCF7 ZsGreen1+ signal and in red 
the UEAI for endothelial cells. Arrows point to different tumor morphologies, named on the basis of the 
literature [51]. Scale bar: 75µm; B) Graphic of the number of cell for cluster (mean values ±SD). * p value< 
0.05. 
We supposed that the array of tumor morphologies in MCF7-µTPs could be linked 
to different environmental micro-heterogeneities. To this aim, we investigated 
collagen folding around tumor cluster. In the same tissue, despite the overall 
desmoplastic reaction, there were both random oriented collagen fibers, close to 
clusters with undefined form, and straightened collagen fibers stretched around 
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tumor cluster arranged in specific morphologies such as solid strand. These 
differences were visible after 10 day of culture when collagen was more mature 
(Fig.11A). Collagen images after 10 days were analyzed in order to obtain a 
distribution of collagen fibers orientations. In Fig.11B on the left it was indicated 
the color map of orientation of the plugin OrientationJ. The image on the top 
(Orange perimeter) didn’t show a preferential collagen orientation whereas in the 
image on the bottom (Blue perimeter) most of the collagen fibers stained yellow-
green and had a preferential orientation at -60°/-30°. On the right it is shown the 
graphic the normalized distribution of orientations. The orange curve is related to 
the image on the top (Orange perimeter) and the blue one to the image on the 
bottom (Blue perimeter). Tumor cluster surrounded by aligned collagen fibers had 
an orientation at about -50°/-30° (Fig.11C), within the range of preferential 
collagen orientation, indicating that the tumor masses were surrounded by collagen 
fibers aligned thereto. 
 
Fig. 11 
Collagen 
heterogeneity: 
A) In green 
MCF7 
ZsGreen1+ and 
in gray the 
SHG signal of 
collagen. 
Images of 
different parts 
of MCF7-µTPs 
3 (up) and 10 
days (down) 
after MCF7 
seeding, at 2 
different 
magnifications. 
Scale bar 
75µm. B) 
OrienationJ 
analysis. On the left the color map related to images on the center, on the right the graphic of the normalized 
distribution of collagen orientations; C) Analysis of the orientations of 4 tumor clusters surrounded by 
preferentially oriented collagen fibers. 
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3.4 Discussion 
In this work, we have developed a breast cancer model able to recapitulate 
spatiotemporal tumor heterogeneity into a dynamic microenvironment in which 
pro-angiogenic response and desmoplastic reaction occur. 
We seeded human metastatic MCF7 on the surface of µTPs made up of HDFs 
embedded into a collagen rich ECM, produced by fibroblasts themselves, and 
HUVECs organized into a capillary-like network.  
MCF7 cell line were derived from the pleural effusion of a 69-year-old female 
patient with a diagnosis of malignant adenocarcinoma of the breast [116]. These 
cells are well-documented in the literature and a suitable model cell line for breast 
cancer investigations worldwide [109].  
Vascularized HDF-µTPs were used as CRTL in this work and they were 
characterized by a growing capillary network until 28 days (Fig.1) without signs of 
morphological regression which can occur in non-perfused vessels [6]. Thus, 
demonstrating that the dynamic culture condition into spinner flask could have 
important implication in the maintenance of angiogenesis even in absence of a 
perfusion flow through capillaries structures, probably because of the shear forces 
into the bioreactor [117] which are known to be correlated with vessel morphology 
and function [118]. 
Another control of our experiments was a healthy mammalian model obtained by 
seeding MCF10 cells on vascularized HDF-µTPs. 
In the healthy model, MCF10, seeded on the surface of the sample, penetrated the 
interstitial space among micro-scaffolds and were able to form acinar structures in 
10 days as typical of normal mammary epithelial cells. On the other hand, in the 
tumor model, MCF7, seeded in the same number and way of MCF10, formed 
disorganized cell masses and maintained higher proliferation rates (Fig.2). These 
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results are in agreement with previous literature data showing the behavior of 
normal and tumor cells in 3D environments [27] [119].  
Our model is able to recapitulate how a healthy microenvironment can be perturbed 
by cancers cells. MCF7-µTPs represent a complex milieu in which tumor cells, 
endothelial cells and the ECM are in mutual interaction.  
Firstly, we analyzed how MCF7 affect angiogenesis. We found that the CLS 
volume fraction and the number of junctions/µm
3
 in tumor tissue were always 
higher than the controls and that they were increasing from 3 to 10 days leading 
major differences at the end of the culture time. Moreover, the average diameters 
length was always higher in tumor tissue with large standard deviations due to the 
cancer characteristic heterogeneities in capillary size. These data indicate that the 
tumor tissue was able to provide pro-angiogenic stimuli inducing the increase of 
the capillary extension, ramification and dimension (Fig.3 and Fig.4).  
Endothelial and tumor cells grew in synergistic way into MCF7-µTPs and they 
were also physically very close. From the immunofluorescence, it is possible to see 
that tumor cells clusters were often aligned to capillary structures (Fig.5A). It’s 
quite frequent to find single file of tumor cells parallel to the vascular network, 
assuming a conformation very similar to circulating tumor cells cluster migrating 
into capillaries [58] but outside these structure. We suppose that this particular 
conformation of tumor cells isn’t only due to the physical confinement which 
capillaries impose on tumor clusters during circulation but also to paracrine signals 
which endothelial cells release affecting cancer cells behavior and that endothelial 
and tumor cells themselves deliver influencing the folding of the ECM. 
The tumor model mirror the ability of tumor cells to attract endothelial cells from 
the environment [120]. In fact, images in Fig. 5C represent MCF7 and HUVECs in 
a very close contact and forming tumor masses crossed and surrounded by a 
discontinuous and intricate vascular network.  
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Furthermore, MCF7-µTPs model showed the presence of mosaic vessels with 
tumor cells becoming part of the capillary wall. The Fig.5 D/E show tumor cells 
cluster into the wall of leaky capillaries. The mosaic wall formation is a 
phenomenon which has profound implications for metastasis, drug delivery, and 
antivascular therapy. Munn et al calculate that half of the tumor cells exposed to 
the vessel lumen are shed into the circulation in a given day. [121] [60]. In line 
with this evidences our results demonstrate that MCF7 maintain their metastatic 
potential in vitro. 
In 10 days, MCF7-µTPs were featured by the activation of the stromal 
desmoplastic reaction (Tab.1) with increase in collagen (Fig.6) and hyaluronic acid 
(Fig.7) amount. In invasive cancers, the collagen matrix is dense and the alignment 
degree is associated with poor prognosis. As in vivo, MCF7-µTPs had high level of 
dense and aligned collagen fibers as demonstrated by the quantitative analysis of 
the collagen fraction and assembly and by the GLCM analysis. Starting from SHG 
images, representing collagen fibers in gray, the correlation quantifies the 
dependence of gray levels between two pixels separated by distance d. The high 
correlation found in tumors indicates that one or several patterns repeat themselves 
inside the computational window and reveal a similar organization of the collagen 
fibers with certain periodicity [122]. The entropy measures the lack of tissue spatial 
organization [123]. The high correlation length and the low entropy values in 
MCF7-µTPs indicate that in 10 days the ECM acquires a certain degree of 
organization which features tumor tissues whereas normal interstitial matrix is 
comprised of cross-linked collagen fibers, generally arranged in non-isotropic 
orientations. This matrix organization can affect the diffusion pattern of molecules 
and drugs [124] and represents a troublesome point to investigate in order to 
develop new therapies for ‘inaccessible tumors’.  
Moreover, the desmoplastic reaction, with increase in collagen density, is also 
linked to the heterogeneous organization of MCF7 in clusters. In fact, previous 
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works showed that epithelial cells within low-density matrix form well 
differentiated acini structures, while colonies that formed within high-density 
matrices are larger and less-organized [46]. The endogenous MCF7-µTPs 
environment, product by fibroblasts and altered by tumor cells, offer the 
opportunity to find different types of tumor cluster organizations which recapitulate 
different morphologies of invasive cancer cells during collective migration and 
metastasis (Fig.10). Cancer cell invasion is a heterogeneous and adaptive process in 
which tumor cells assume different migrations modes into the matrix in order to 
stay always motile and move toward vessels [51]. The various cluster conformation 
that we identified in the same tissue and at different time points are the mirror of 
different environmental conditions dictated by the ECM, fibroblasts and 
endothelial cells.  
Among the different morphologies, 
when tumor cells were near to 
capillaries, they arranged parallel to 
them, as discussed before, or in cluster 
driven by leader cells which seemed to 
point the endothelium. This spiculated 
contour reminds that observed by 
mammography (Fig.10) and 
considered as positive predictive value 
of malignancy [125].  
MCF7-µTPs model uniquely 
recapitulates spatiotemporal 
heterogeneity of tumor cells 
organization and environment, as demonstrated by the morphological analysis of 
tumor cluster as well as collagen fibers orientation analysis. In vivo, tumor 
heterogeneity is associated with cancer resistance during therapy [51] and the 
Fig. 10 Invasive ductal carcinoma, not otherwise 
specified (IDC, NOS). Close-up of mammogram with x-
ray beam tangential to the area of skin retraction shows 
the underlying oval, spiculated, high density mass 
representing carcinoma [146]. 
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opportunity to have an in vitro model with this feature represents an intriguing 
chance for the study of these mechanisms and for the development and test of new 
drugs. 
Taking together, our results show that MCF7, embedded into a dynamic matrix 
produced by human fibroblasts, have pro-angiogenic effect on the vascular 
network, are able to activate the desmoplastic reaction of the stroma and retain 
heterogeneous invasive properties into the matrix.  
MCF7 were generally described in the literature as cells with low invasiveness, 
migration ability and pro-angiogenic effect in vitro [126] [72] [108] [109], 
although being metastatic breast cancer cells from pleural effusion in vivo. Our 
results highlight that the microenvironment has deep implications for cell behavior 
in vitro and demonstrate that MCF7-µTPs context is able to provide appropriate 
stimuli for the maintenance of tumor features in vitro. 
We speculate that MCF7-µTPs can serve as unique multicomponent platform 
representative of fundamental aspects involved in tumor progression. 
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3.5 Conclusions and Future Perspectives 
This work focus on the development of a new breast cancer model representative of 
the multiplicity of events occurring during tumor genesis and progression. The 
vascular response, the stromal desmoplastic reaction, cancer cell invasion and 
mosaic vessels formation have a central and active role in metastatic breast cancer 
and could be target of therapies.  
We show that MCF7 cell line into a human ECM, rich in dense collagen product by 
mammary fibroblasts, retain their invasive phenotype and display higher pro-
angiogenic properties than control and healthy tissues. 
Here we present MCF7-µTPs as complex model for the study of tumor features and 
as platform for drug screening. 
MCF7-µTP is an in vitro model for the study of the heterogeneity featuring in vivo 
tumors and molecular event associated with tumor growth and progression, into a 
microenvironment which converts from a normal to an activate/pathological 
condition and that is influenced and in turn influence cancer cells behavior. 
About drug screening, at now, it could be possible study of the diffusion of active 
principles across the dense extracellular matrix and their effect on tumor 
vasculature, stroma and migration ability. We provide some benchmarks for the 
study of the vascular network and the stroma in healthy and pathological micro-
tissues. In the future it might be interesting to examine other quantitative aspects of 
tumor heterogeneity in order to optimize the model for drug-screening. 
Moreover, it will be very interesting to integrate MCF7-µTP into specific 
microfluidic systems in order to find a way to perfuse them and study the outcomes 
of systemic drugs. 
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Chapter 4 
 
 
 
Development of vascularized 
dermis/skin equivalent model 
featured by endogenous 
extracellular matrix 
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4 Abstract 
The presence of a pre-vascularized network into engineered tissue can accelerate 
the formation of functional anastomosis with host vasculature after in vivo graft, 
ensuring the sustenance of the implant, its integration and long term survival. This 
is fundamental for full thickness grafts for example after burns, surgery loss 
substance or injury leading tissue necrosis. 
In the same time, in vitro, it can be a suitable model in view of fundamental 
research about angiogenesis and industrial applications like drugs screening.  
Despite the improvements occurred in the issue of vascularized engineered tissues, 
actually there aren’t skin or dermal pre-vascularized substitutes used in the clinic. 
One of the major challenges is to obtain a pervious and stable vascular network 
within a construct with good mechanical strength, poor deformability and 
controlled degradation of the scaffold. 
Using a bottom-up approach, we have developed a dermis/skin equivalent model in 
which endothelial cells deeply penetrate and form mature capillary-like-structures 
branching within a collagen rich extracellular matrix produced by fibroblasts and 
able to offer pro-angiogenic signals leading the physiological development of the 
network itself.  
Endothelial cells are able to migrate during wound heling assay and follow 
geometric control imposed by specific dermis shapes.  
Keratinocytes seeded on the vascularized dermis equivalent develop a stratified, 
keratinized and differentiated epithelium. 
We speculate that this model could be useful for in vivo applications in order to 
repair and restore damaged tissues. Furthermore, the construct could have 
interesting in vitro applications for the study of angiogenesis and drugs or 
molecules acting via topical administration. 
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4.1 Introduction  
The main compartments of the skin are the epithelium and dermis. The epithelium 
is the top layer of the skin, which comprised mainly of keratinocytes. It provides 
the barrier against exogenous substances, chemicals, pathogens and prevents 
dehydration through the regulation of fluid loss. Beneath the epidermis, the dermis 
is a thicker layer of connective tissues that consists mainly of extracellular matrix 
(ECM) or structural components (predominantly collagen and elastin) which give 
mechanical strength and elasticity and a vascular plexus for skin nourishment. 
Cells interspersed within the ECM (Extracellular Cell Matrix) include fibroblasts, 
endothelial cells, smooth muscle cells and mast cells [87]. Skin model try to 
reproduce human skin structure and function and are mainly achieved seeding 
fibroblasts within 3D scaffold able to mimic the functions of the extracellular 
matrix in order to obtain the dermis compartment and following seeding of 
keratinocytes to develop the epithelium [93]. Typical 3D matrix used as scaffold 
are decellularized matrix, collagen type I, collagen-glycosaminoglycans, fibrin, 
fibroblasts derived matrix or synthetic polymers [22]. Several works used hydrogel 
as scaffold because of their similarity with the extracellular matrix but in the main 
time they have poor mechanical properties and are of animal origin [127]. 
Over the past 30 years Tissue Engineering has made numerous efforts to get 
substitutes that mimic the structure and function of human skin [93]. This is 
important for several reasons. Firstly, these substitutes can be used in the clinic in 
order to replace and restore damaged tissues e.g. after burns, surgery or pathology 
leading tissue necrosis, when it is not possible to perform an autograft because of 
the extension and thickness of the injured area [87] [95]. Besides their use as in 
vivo grafts other applications have emerged for skin substitutes as in vitro test 
systems. In this context, they enable not only the investigation of fundamental 
processes in the skin, but also the hazard assessment of various chemical 
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compounds that are topically applied on the skin without the need to use animal 
models [93].  
At now, several epithelial/dermal/skin models are effectively used in the clinic and 
as platform for in vitro testing by pharmaceutical or cosmetic companies [93] [87] 
[128]. 
Despite the availability of these commercial products, they all suffer from the same 
problems of extremely high cost, sub-normal skin microstructure and inconsistent 
engraftment, especially in full thickness graft [87]. 
Furthermore, one of the major problems of full thickness skin graft is that it is 
slowly vascularized in vivo, so increasing time of tissue complete integration with 
host. About this issue, vascularization strategies in Tissue Engineering come in 
help with the aim to obtain a faster vascularization promoting graft invasion by 
host vessels or developing pre-vascularized models. Scaffolds can be 
functionalized using pro-angiogenic growth factors such as VEGF (Vascular 
Endothelial Growth Factor), PDGF (Platelet-derived Growth Factor) or heparin, 
but the effective use of these scaffolds is limited by the difficulty to adjust the 
release kinetics in vivo [2].  
In several works pre-vascularization strategies are based on the co-culture of 
endothelial cells with other cell types. In fact when endothelial cells are cultured in 
vitro under permissive conditions, in particular when they are in 3D co-culture with 
other cell types and a relevant ECM, spontaneously are capable to form capillary 
networks [1]. Auger et al in 2006 have shown that fibroblasts promote the 
proliferation of endothelial cells, their migration and angiogenesis. This is due to 
their ability to produce an organized ECM and growth factors that represent the 
microenvironment suitable to promote the organization of endothelial cells in 3D 
and the formation of capillary-like tubular structures [9]. 
The first vascularized skin equivalent model is to Auger et al in 1998. They 
fabricated a collagen/Chitosan biopolymer in which three human cell types—
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keratinocytes, dermal fibroblasts, and umbilical vein endothelial cells—were co-
cultured. In this context endothelial cells develop a mature capillary network in 31 
days [129].  
It was demonstrated that the presence of a capillary network into an engineered 
skin model can quickly guarantee the formation of functional anastomosis with 
host vessels in 4 days whereas de novo vascularization of non-vascularized 
construct by host vessels is a longer process and require at least 14 days depending 
on the size of the implant [103]. 
Recent studies show the possibility of achieving engineered skin models pre-
vascularized by an extensive network of both blood and lymphatic vessels. 
Reichmann et al used a co-culture of endothelial cells and fibroblasts in collagen 
I/fibrin hydrogel. In particular, they used HDMECs (Human Dermal Microvascular 
Endothelial Cells) extracted by foreskin and including a mixed endothelial cells 
population. After three weeks of in vitro culture cells organize themselves into 
blood and lymphatic structures which, interestingly, never anastomose between 
them in vitro. After implantation successful anastomosis were achieved between 
lymphatic vessels of the construct with the host ones as well as for blood vessels 
[4].  
Despite the improvements occurred in the issue of vascularized engineered tissues, 
actually there aren’t skin or dermal pre-vascularized substitutes used in the clinic.  
The gold standard skin substitute should be physiologically vascularized, easily 
handled, poor deformable, able to withstand the shear forces in vivo and 
transplantable in one surgical intervention without scarring [130].[131]. The 
scaffold should be biodegradable in a controlled manner and non-immunogenic 
[132]. 
Here we show the development of a vascularized dermis/skin equivalent model 
obtained by bottom up approach. The model is strengthened by a collagenous 
matrix product by fibroblasts and able to offer pro-angiogenic stimuli for 
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endothelial cells sprouting and ramification. The vascular network recapitulates all 
the events of physiological angiogenesis with the formation of a capillary network 
and its following regression. VEGF and Ang-2 are together involved in vessel 
formation and remodeling whereas Ang-2 alone is linked with vessel regression. 
The vascular network gains structural maturity in vitro, being surrounded by 
collagen, laminin and pericytes-like cells. 
We speculate that the vascularized dermis equivalent could be suitable for clinical 
applications for several reasons. Previous works showed that the dermis model 
exhibit increasing mechanical strength until 6 weeks of culture [23], it is easy to 
handle and has tunable shape and dimensions[21] [22] [23]. Moreover the scaffold 
degradation occurs in vitro with known timing [94] allowing the further synthesis 
of new tissue. Here we show that such environment allows the physiological 
evolution and maturation of the vascular network. Furthermore, endothelial cells 
are able to migrate during wound assay and to follow geometric controls imposed 
by modeling dermis shape, so placing increasing confidence in their ability and 
chance to form anastomosis in vivo.  
Keratinocytes, seeded on a surface of the vascularized dermis model, develop a 
stratified and differentiated epithelium which could give barrier function in specific 
cases of graft.  
Furthermore, a so representative vascularized model could be useful to study 
angiogenesis and as platform to examine the effect of topically administered 
compounds. 
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4.2 Materials and Methods 
4.2.1 HDFs and Keratinocytes source 
Cells were extracted from human tissue biopsies surplus obtained by “Azienda 
Ospedaliera di Rilievo Nazionale e di Alta Specializzazione (AORN) A. 
Cardarelli/Santobono/Pausillipon at Urology and Biotechnology Centre - AORN” 
according to the project “Realization of human skin equivalent in vitro” after 
approval of ethical committee. 
4.2.2 HDFs and Keratinocytes extraction 
All the solutions used during the extraction procedure were cool. Human biopsies 
were washed in PBS1X+antibiotics (1%penicillin/streptomycin- Microgem L0022-
100- or 50µg/ml gentamicin- SIGMA G1397), PBS1X+antimycotic 
(1%Amphotericin-SIGMA A2942-) and PBS1X. Fat from the bottom side was 
removed as much as possible with a scalpel and the tissue was washed again in 
PBS1X. The skin biopsy was cut into strips of about 3mm width and incubated 
Dispase (GIBCO 0698) solution 1.8U/mL overnight for 14h. 
Epidermis and dermis were separated with tweezers and then washed in PBS1X. 
The dermal pieces were cut in smaller pieces and put in 2,5mg/ml collagenase A 
solution (ROCHE 11088793001) for 40 minutes at 37°C. The collagenase was 
stopped with FBS and then removed. All the pieces were suspended in a little 
volume of complete MEM and arranged on a petri dish in order to allow the 
migration of fibroblasts on the surface of the petri.  
Epidermal parts were washed with PBS1X and cut into smaller pieces and 
incubated with preheated Trypsin/EDTA (Microtech L0930-100) for 5 min at 37°C 
water bath. The enzyme reaction was stopped by adding FBS. The solution was 
pipetted vigorously for 5’ in order to separate cell clumps and then centrifuged for 
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5’ at 1200 rpm. Cells were suspended in the culture media and seeded at high 
density (about 30.000 cells/cm²). 
4.2.3 Cell culture 
Human dermal fibroblasts (HDFs) were extracted from healthy foreskin or breast 
biopsies and cultured in enriched MEM: MEM (Microtech L0440-500) with 20% 
of FBS (Sigma Aldrich), 2% of Non-Essential Aminoacids (EuroClone 
ECB3054D), 1% of L-Glutamine (Lonza 17-605E) and 1% of 
penicillin/streptomycin (Microtech L0022-100), until passage 4/7.  
HUVECs (GIBCO C0035C) were cultured in enriched M200: M200 (GIBCO 
Invitrogen Cell Culture M-200-500) supplemented with LSGS Kit (GIBCO 
Invitrogen Cell Culture S-003-K) until passage 3. 
Human keratinocytes were grown KGM-2 culture media (PromoCeLL C-20111) 
and were used for the experiments at passage 1. 
4.2.4 Micro-scaffold production 
Gelatin porous microbeads (GPMs) were prepared according to a modified double 
emulsion protocol (O/W/O) [110]. GPMs were stabilized by crosslink reaction with 
glyceraldehyde (GAL) (SIGMA-G5001), in order to make them stable in aqueous 
environment at 37 °C, as previously described [94]. GAL at 4% w/w of the 
microbeads was used to perform all the experiments. 
4.2.5 Micro-tissues (µTPs) production 
About 11 HDFs P5/8 were seeded for bead. Cells were cultured into spinner flask 
bioreactor (Integra) in continuous agitation (30 rpm) after 6 hours of intermitting 
stirring regime in order to promote cell seeding (30 min at 0 rpm, 5 min at 30 rpm). 
The culture medium was enriched MEM plus Ascorbic Acid (2-O-α-D-
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Glucopyranosiyl-L-Ascorbic-Acid TCI; Cf: 0.5mM). µTPs were cultured for 9 
days before the phase of assembly in order to guarantee the initial collagen 
synthesis. 
4.2.6 Dermis equivalent model production 
As previously described [117] μTPs suspension was transferred from the spinner 
flask to a 50 ml Falcon centrifuge tube and, after settling, transferred by pipetting 
into the maturation chamber to allow their molding in disc-shaped construct (1 mm 
in thickness, 5 or 8 mm in diameter). During the filling procedure, the maturation 
chamber was accommodated on a device connected with a vacuum pump to make 
the process faster and to assure that any bubble was in the maturation space. The 
assembling chamber was a sandwich-like structure with in the middle a silicon 
mold with empty spaces (disc shape:1 mm in thickness, 5 or 8 mm in diameter; 
wire shape:  1 mm in thickness, 5cm length) for the μTPs housing. A particular 
conformation of the mold was used in order to obtain channeled biohybrids: a 
capillary with outside diameter of 364µm and inner diameter of 74µm (Polyimide 
Coated Fused Silica Capillary Tubing, Molex TSP075375) was inserted into the 
empties spaces (disc shape: 1 mm in thickness, 8 mm in diameter) of the mold, as 
stamp around which allow tissue assembly. 
The silicon mold was delimited on both the top and bottom sides by two stainless 
steel rigid grids characterized by a porous mesh (18 µm) that was able to retain the 
μTPs and to guarantee the passage of nutrients and waste products. Two 
polytetrafluoroethylene (PTFE) rings were placed on the grids on both sides of the 
system and were fastened to each other by means of stainless steel screws, which 
close the system. 
The assembling chamber was placed on the bottom of a spinner flask (Bellco 
biotechnology code 1967- 00050) and completely surrounded by culture medium. 
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The spinner was operated at 60 rpm. The culture medium was enriched MEM plus 
Ascorbic Acid. After 4-5 weeks of culture the assembling chamber was opened and 
biohybrids were collected. 
4.2.7 Vascularized dermis equivalent model production 
Endothelial cells seeding and culture was performed into multiwall low attach in 
order to avoid cells adhesion on the surface of the petri and to allow cells adhesion 
on the biohybrid dermis equivalent. HUVECs P4 were seeded as a drop on a 
surface of the sample, at high density of about 10.000/15.000 cells for mm
2
. Cells 
were suspended in 5-10µl of medium, depending on the size and form of the 
biohybrid, in order to avoid drop falling. After the seeding, the sample was left at 
37°C for 2 hours enabling endothelial cells adhesion and, afterwards, complete 
medium was added up to completely cover the sample. During the first 2 hours, the 
sample was monitored to avoid drying and eventually a drop of medium was added 
on the surface. M200 complete was used for cell seeding and adhesion, while from 
the following day complete MEM and M200 were used in 2:1 ratio. Samples were 
cultured for 3 weeks. 
4.2.8 HUVECs injection into the channeled biohybrid dermis equivalent 
After the maturation period the assembling chamber was opened and biohybrids 
assembled around the capillary structure were derived. The capillary was pulled out 
from the sample leading the channel structure. One extremity of the capillary was 
left inserted into the initial part of the channel whereas the other one was connected 
to another longer capillary (length 10cm), by a silicon connector hand made by us, 
in turn attached to a syringe pump. HUVECs P3 were detached and charged into a 
syringe at a density of 1.500 cells/µl within a final volume of 100µl. Cells were 
injected using a syringe pump at an initial flow rate of 50µl/min for few minutes in 
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order to release any bubbles from the channel and then at a flow rate of 1µl/min. 
Sample was rounded after the injection of 50µl of cell solution and cycles of 
injection and stop (less than 1 minute) were alternated during the entire procedure 
in order to allow cells seeding. 
4.2.9 Vascularized skin equivalent model 
1week after HUVECs seeding the sample was rounded and placed on a transwell 
insert (with pores of 3.0 µm) in order to seed on the opposite surface keratinocytes. 
The dermis equivalent surface was coated using 50µg/ml human fibronectin 
(Sigma Aldrich F0895). The coating was performed with a minimal volume of 
about 5-10 µl of fibronectin. Samples were left under hood, at RT, for 40’ and into 
the incubator, at 37°C, for 10’. Meanwhile human keratinocytes were washed 3 or 4 
times with PBS/EDTA 0.01 M (Invitrogen 15575-038) for few minutes. Cells 
colonies were detached by using trypsin/EDTA (Microtech L0930-100) for 5 min 
at 37 °C. Cells were counted and the appropriate number of cells was transferred 
into a Falcon tube and centrifuged at 1.200 rpm for 5’.  
About 4.000 cells/mm2 were seeded on the surface of the biohybrid, suspended in 5-
10µl of medium, depending on the size of the sample, in order to avoid drop 
falling. After 3hours the sample was submerged with the medium: complete KGM-
2+5%FBS and CaCl2 0.06 mM. The next day the medium was changed with 
complete KGM-2+ 3%FBS and CaCl2 0.06 mM2 days later with complete KGM-
2+ 3%FBS and CaCl2 0.06 mM until the 6th day of submerged culture. During the 
following 2 weeks of culture the sample was elevated at the air liquid interface 
using a complete KGM-2 medium without EGF and BPE and with CaCl2 1.88 
mM.  
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4.2.10 Immunofluorescence analysis 
 Immunofluorescence on the whole sample 
Sample were fixed in 4% Paraformaldehyde (P61148-500g Sigma Aldrich) for 30’ 
at RT and washed in PBS1X. They were permeabilized using 0,1% Triton (Triton® 
X-100 T9284-100ML Sigma) in PBS1X for 5’ at RT, washed in PBS1X and 
blocked in 1%BSA (A9418-100G Sigma) for 1h at RT. Samples were stained with 
Rhodamine Ulex Europaeus Agglutinin I (UEAI Vector Laboratories RL-1062) at 
a final concentration of 20μg/ml in blocking solution, in order to mark the 
endothelium, overnight (ON) at 4°C in the dark. The morning after, samples were 
washed with PBS1X. The nuclei of all the cells were stained with Sytox Green 
(Invitrogen S7020) for 20’ at RT.  
 Samples clarification 
Samples were dehydrated by serial immersions, each of 30’, in Methanol 50%, 
70%, 80%, 90%, 100%, 100%. BABB solution was prepared containing Benzyl 
Alcohol (BA) and Benzyl Benzoate (BB) (SIGMA) in 1:2 ratio. Samples were 
moved into a glass bottle and treated with Methanol and BABB (1:1) for 4h and 
following with BABB for 24h at RT. Samples were investigated into fluorodish by 
Confocal Leica TCS SP5 II.  
 Immunofluorescence on frozen tissue sections 
Sample were fixed in 4% Paraformaldehyde (Sigma Aldrich P61148-500g) for 30’ 
at RT, washed in PBS1X and soaked into a sucrose water solution (2 M). After 24h 
samples were included in OCT Killik (Bio Optica 05-9801) in a suitable mold 
(Peel-A, Ted Pella INC), submerged in liquid nitrogen vapors for 1 minute and 
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then stored at -80 °C. All samples were cut in slices 7 μm in thickness by using a 
criomicrotome (Leica CM 1850). 
For immunofluorescences analyses, tissue slices were washed in PBS1X to remove 
the fixative and then permeabilized and blocked with 0.01% Triton X-100 in 
PBS/BSA 3% for 2h at RT. Subsequently, slices were incubated ON in presence of 
the primary antibodies: UEAI (Cf 20µg/ml), Mouse monoclonal Anti alpha-SMA 
(1:100, Abcam ab7817), Rabbit polyclonal anti Laminin (1:30, SIGMA L9393). 
The morning after samples were washed in PBS1X and the secondary antibodies 
Alexa Fluor 488 Goat anti-Mouse IgG (H+L) (1:500, Thermo Fisher Scientific 
A11001) and Alexa Fluor 488 Goat anti-Rabbit IgG (H+L) (1:500, Thermo Fisher 
Scientific A11008) in PBS1X BSA3% were added for 1h and half at RT. Nuclei 
were stained with DAPI (Sigma-Aldrich D9542) and samples were investigated by 
Confocal Leica TCS SP5 II. 
 Immunofluorescence on paraffin sections 
Samples were fixed in Formalin 10% (Sigma HT501320) for 1h at Room 
Temperature (RT) and washed in PBS1X (Sigma P4417-100TAB). They were 
dehydrated in Ethanol from 75% to 100% and treated with Xylene (A9982 
ROMIL) before the inclusion in Paraffin. Tissue slices thick 7µm were cut using a 
microtome (Thermo Scientific HM 355S) and then deparaffinized using xylene. 
Sections were hydrated in ethanol from 100% to 75% and washed in water, Triton 
0,2% and PBS1X. In order to release the epitopes from paraffin, heat mediated 
citrate buffer (pH=6, Thermo scientific TA-125-PM1X) unmasking was performed. 
Sections were washed in PBS1X, blocked using BSA6%, FBS 5%, MgCl2 20Mm 
and Tween20 0,02% in PBS1X for 2h at RT and incubated with the primary 
antibodies ON at 4°C in a wet environment: p63 Mouse anti-p63(1:50, Invitrogen 
4B1E12), k10 (1:500, Covance PRB-159P-100), k14 (1:500, Covance PRB-155P-
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100), involucrin (1:500, Covance PRB-140C), filaggrin (1:500, Covance PRB-
417P). 
The morning after samples were washed in PBS1X and the secondary antibodies 
Alexa Fluor 488 Goat anti-Mouse IgG (H+L) (1:500, Thermo Fisher Scientific 
A11001), and Goat Anti-Rabbit IgG (H+L) Secondary Antibody Alexa Fluor 488 
(1:500, A11008) and Donkey Anti Rabbit IgG (H+L) Alexa Fluor 546 (A10040) in 
PBS1X were added for 1h and half at RT. Nuclei were stained with DAPI and 
samples were investigated by Confocal Leica TCS SP5 II.  
4.2.11 Histology on paraffin sections 
Samples were fixed in Formalin 10% (HT501320 Sigma) for 1h at Room 
Temperature (RT) and washed in PBS1X (P4417-100TAB Sigma). They were 
dehydrated in Ethanol from 75% to 100% and treated with Xylene (A9982 
ROMIL) before the inclusion in Paraffin. Tissue slices thick 7µm were cut using a 
microtome (Thermo Scientific HM 355S) and then deparaffinized using xylene. 
Sections were hydrated in ethanol from 100% to 75%, washed in water and stained 
using Hematoxylin/Eosin (Bio Optica W01030708). The sections were mounted 
with Histomount Mounting Solution (Bio Mount HM 05-BMHM500 Bio-Optica) 
on coverslips and the morphological features of μTPs were observed with a light 
microscope (Olympus, BX53). 
4.2.12 Second harmonic generation signal 
For SHG imaging samples were investigated by confocal microscopy (TCS SP5 II 
Leica) combined with a MPM where the NIR femtosecond laser beam was derived 
from a tunable compact mode-locked titanium: sapphire laser (Chamaleon 
Compact OPO-Vis, Coherent). Two-photon excited fluorescence was used to 
induce second harmonic generation (SHG) and obtain high-resolution images of 
111 
 
unstained collagen structures. The samples were observed by using λex = 840 nm 
(two photons) and λem=415-425 nm. The SHG images were acquired with a 
resolution of 12 bit, 512x512 pixel by using a 25X water immersion objective (HCX 
IRAPO L 25.0X0.95 Water, n.a. 0.95). 
4.2.13 Scanning electron microscopy (SEM) 
SEM was performed to analyze the morphology of channeled biohybrids. Fixed 
samples were dehydrated in an incremental series of Ethanol (50%, 75%, 85%, 
95% and 100% at room temperature) followed by critical point drying (CPD-300 
Leica). Then they were mounted onto metal stubs and then coated with 100 A 
ultrathin platinum layer (thickness 7 nm) in a glow-discharge coater to minimize 
charging and increase the conductivity of the biological material (sputter coater 
Cressington_HR 208). Images were acquired using InLens and SE2 detectors 
(SEM, FEG_Ultrapluss by ZEISS). 
4.2.14 Quantitative Capillary-like structures (CLS) analysis 
Whole samples were investigated by Confocal Leica TCS SP5 II performing 5 z-
stacks in different random points of different μTPs. Samples were observed using 
λex = 543 nm/ λem=550/560 nm to detect Rhodamine and λex=488 nm/ 
λem=500/530 nm to detect Sytox Green. The stacks were acquired with a 
resolution of 12 bit, 512x512 pixels by using a 25X water immersion objective 
(HCX IRAPO L 25.0X0.95 Water, n.a. 0.95). Each stack was composed by 16 
sequential images with a z-slice-space of 1,98 µm. 
 CLS volume fraction 
The capillary like structures (CLS) volume fraction was calculated as percentage of 
the ratio between the thresholded red volume of the endothelium marked by 
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Rhodamine-UEAI and the total volume of the sample acquired for each stack. The 
volume values were obtained applying the ImageJ plugin Measure Stack to the red 
thresholded channel and to the total volume of tissue acquired. 
  
CLS Volume fraction =
acquired CLS volume
acquired sample volume
∗ 100 
 Analysis of the junctions 
The number of junctions for each stack was calculated using the plugin Skeletonize 
3D of ImageJ. Before the analysis, the red channel of each stack was thresholded 
and smoothed in order to avoid the identification of false positive junctions by the 
plugin. The number of junctions for μm3 was calculated as ratio between the 
number of junctions for stack and the total acquired volume obtained by Measure 
Stack. Thanks to the plugin Skeletonize 3D of ImageJ we were able to distinguish 
triple and quadruple points of junction. 
 
Junctions/μm3 =
n° of junctions for stack
acquired sample volume
 
 CLS diameter analysis 
The diameter of the capillary like structures was calculated tracing at least 3 
adjacent lines joining the opposite major sides of capillaries using ImageJ. For each 
sample the diameter was calculated at least three times on each image of the z stack 
and then the mean and the standard deviation were represented in the graphic.  
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4.2.15 Molecular analysis 
Vascularized biohybrid dermis equivalent, 1, 2 and 3 weeks after HUVECs 
seeding, were weighed, cut and treated with 2,5mg/ml Collagenase A (ROCHE) for 
30’. Samples in lysis buffer were placed into 2ml Eppendorf with a stainless-steel 
ball for mechanical digestion on a vortex. RNA extraction was performed by means 
of the High Pure RNA Tissue Kit (ROCHE 12033674001) according to 
manufacturer’s protocol. Lysates were centrifuged into high pure filter tube. The 
flow through was discarded and samples were incubated in presence of DNase and 
DNase Incubation buffer for 15’ at RT. Washing buffer 1 with Ethanol was added 
and samples were centrifuged for 10’’ at 10.000 rpm and flow through was 
discarded, so for washing buffer 2. After a second wash in Buffer 2, samples were 
centrifuged for 2’ at 13.000rpm. Finally, RNA was eluted in 50µl of elution Buffer 
after centrifugation for 1’ at 10.000rpm. RNA was quantified by means of 
spectrophotometer (Eppendorf Bio Photometer). 100ng of RNA were retro-
transcribed using iScript™ Reverse Transcription Supermix (Biorad 1708840). 4µl 
of super-mix and water were added to samples up to a final volume of 20µl. The 
complete reaction mix was incubated in a thermal cycler using the following 
protocol: 5’ at 25°C, 30’ at 42°C and 5’ at 85°C.  
Real Time PCR was performed using BIORAD CFX96 Real-time system C100 
Touch Thermal cycler. 2,5µl of cDNA were mixed with iQ™ SYBR® Green 
Super-mix (Biorad 170-8880), 0.6µl of Forward and 0.6 µl Reverse Primers (from 
stock solutions 100µM) and water to a final volume of 10µl. 
All quantifications were normalized with the GAPDH mRNA level, then the fold 
induction was calculated by the ΔΔCt method as described in the original paper 
[133]. 
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Table 3 Oligonucleotides sequences 
Gene For 53’ Rev 3’5’ 
VEGF CGAGGCAGCTTGAGTTAAACG AGATCTGGTTCCCGAAACCCT 
ANGP2 GGTGGTTTGATGCATGTGGTCCTT TCTGCTGGTCGGATCATCATGGTT 
HIF1α TTGGCAGCAACGACACAGAAACTG TTGAGTGCAGGGTCAGCACTACTT 
THBS1 TGACAAGGACAACTGCAGACTCGT AGGAATCATCTGGAATCGGCGGAA 
GAPDH CCACCCATGGCAAATTCCATGGCA TCTAGACTGGCAGGTCAGGTCCACC 
 
4.2.16 Decellularization protocol 
We used a protocol exploiting non-ionic detergent, adapted from [134]. Dermis 
pieces after 3 weeks of maturation were treated with 0.25% trypsin for 4 hours at 
RT, H2Od x 15’ (3x), 70% EtOH x 10-12 h (1x), 3% H2O2, 15’ (1x), H2Od x 15’ 
(2x), 1% Triton X-100 in 0.26% EDTA/0.69% Tris (SIGMA) (ON), H2Od x 15’ 
(3x), 4% EtOH x 2 h (1x), PBS x 15’(2x) and H2Od x 15’ (2x). 
4.2.17 Endothelial contribution during wound healing 
After 5 weeks of maturation the assembling chamber was opened and HUVECs P4 
were seeded on a surface of the biohybrid, made up of breast HDFs P7, and 
cultured in multiwell low attach in MEM:M200 (2:1). 10 days after seeding 
biohybrids were cut and the extremities of different samples with HUVECs or with 
and without HUVECs were placed in contact and closed again into the maturation 
chamber, similarly as previously described [135]. Samples were harvested 1 and 2 
weeks after cut, they were stained with UEAI and Sytox and analyzed by Confocal 
Leica TCS SP5 II. 
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4.2.18 Statistics 
Experiments were performed in triplicate. Data are expressed as mean ± SD. 
Differences between groups were determined using the statistic test ANOVA 
Tukey HSD test. Significance between groups was established for p value<0.01 or 
p value<0,05. 
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4.3 Results 
4.3.1 Vascularized dermis equivalent model: characterization 
 HUVECs sprouting into the dermis equivalent model 
In this work HUVECs were seeded on the surface of a biohybrid dermis equivalent 
rich in collagen product by fibroblasts (Fig.1A). Endothelial cells deeply penetrated 
the ECM for about 700µm after 1week (Fig.1B) and formed capillary like 
structures observable from 1 to 3 weeks after HUVECs seeding (Fig.2A). 
 
Fig. 1 3D views of the biohybrid dermis equivalent and vascularized dermis equivalent: A) In gray the 
SHG signal of collagen and in green the HDFs nuclei marked by Sytox; B) On the left the SHG signal of 
collagen and on the right in red the endothelial cells marked by UEAI. 
 CLS image analysis: volume fraction and n° of junctions/µm3 
The image analysis of the CLS volume fraction and of the number of junctions/µm
3
 
showed an increment from 1 to 2 weeks and a decrement from 2 to 3 weeks after 
HUVECs seeding (Fig.2B/C). Most of the analyzed junctions were triple, so among 
3 structures (Fig.2C/D). 
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Fig. 2 CLS in vitro progression: A/D) in red the HUVECs marked by UEAI and in green the nuclei of all the 
cells marked by Sytox; A) Images of CLS 1, 2 and 3 weeks after HUVECs seeding. Scale bar 100µm; B) 
Graphic of the CLS volume fraction and C) Graphic of the number of junctions for µm3; B/C) * p value<0.05 
or p<0.01. D) Image of CLS, the yellow dot represents a triple junction among 3 structures. Scale bar 75µm. 
The capillary network was embedded into the collagen rich ECM produced by 
fibroblasts. The orthogonal view (Fig.3) and images at great magnification (Fig.4) 
showed that these structures were hollow. 
 
 
Fig. 3 CLS embedded into the ECM: A) 3D view of the vascularized dermis equivalent model, in red the 
HUVECs marked by UEAI and in green the nuclei of both HUVECs and HDFs. Scale bar 100µm; B)3D view 
showing the SHG signal of collagen in gray and CLS in red; C) Orthogonal view of CLS. 
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 CLS diameters 
The diameter of the vessels, calculated from image analysis, was of about 9±3µm. 
The structures are showed at greater magnification in Fig. 4. 
 
Fig. 4 CLS structures: In red the HUVECs marked by UEAI. Scale bar 50µm. 
 Molecular analysis 
 The expression of the Vascular Endothelial Growth Factor (VEGF), Angiopoietin2 
(ANGP2), Hypoxia inducible factor (HIF1α) and thrombospondin (THBS1) were 
evaluated by Real Time PCR. VEGF and ANGP2 were upregulated compared to 
the control (not vascularized dermis equivalent) 1 and 2 weeks after seeding and 
the upregulation was increasing from 1 to 2 weeks. Only ANGP2 was upregulated 
after 3 weeks whereas VEGF expression was similar to the control. The HIF1α was 
slightly upregulated in the vascularized dermis only 2 weeks after seeding. THBS1 
didn’t seem to be involved in this process because its expression level was always 
comparable with the control (Fig.5).  
 CLS structural maturity 
In 2 weeks of culture some of the cells surrounding capillaries acquired positivity 
for α Smooth muscle actin (αSMA) and the ECM develop a continuous layer of a 
Collagen and Laminin around vessels as shown by the immunofluorescence (Fig. 
6) 
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Fig. 5 Molecular analysis of factors involved in angiogenesis: The vascularized dermis was compared to the 
dermis without endothelial cells in the same culture conditions. *p<0.05. 
 
Fig. 6 Structural vessels maturity: In blue the nuclei of all the cells marked by DAPI, in red the HUVECs 
marked by UEAI, in green the αSMA and Laminin, in gray the SHG signal of collagen fibers, the arrow 
indicates thicker collagen bundle around capillaries. Merges of the images are on the right. Scale bar 50µm for 
the first 2 lines and 75µm in the last one. 
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4.3.2 Vascularized dermis equivalent model: Assessment of tissue 
function for in vivo application 
We argue that the vascularized dermis model could be used for in vivo studies after 
10 days of culture because in this time structures are still evolving in vitro and they 
have achieved a certain degree of structural maturity. For the in vivo study, we 
want to analyze the time of tissue integration comparing the vascularized dermis 
model with the dermis and the decellularized dermis model. 
 Dermis decellularization 
Using a decellularization protocol exploiting non-ionic detergent we were able to 
remove all the cells from the dermis model keeping intact the collagen structure as 
shown by the SHG signal image (Fig.7). 
 
Fig. 7 Decellularized dermis model: Control and decellularized dermis model using non-ionic detergents. In 
green the nuclei marked in Sytox and in gray the second harmonic generation signal of collagen. Scale bar 
75µm. 
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 Endothelial behavior in wound healing 
In order to assess endothelial cells ability to migrate in the wound area between 
host and implant after graft we performed a wound healing assay [135]. Cut 
biohybrids were placed near into the maturation chamber in both the conformations 
of vascularized biohybrids or vascularized and not vascularized biohybrid. In both 
cases the HUVECs migrated in the wound area which narrows visibly from 1 to 2 
weeks (Fig.8).  
 
Fig. 8 HUVECs migration in the wound area: Images of the cut biohybrids on the left. On the right images 
and 3Dviews of endothelial cells in red marked by UEAI and collagen in gray marked by SHG. The nuclei of 
all the cells were marked in blue by DAPI. Scale bar 100µm. 
 Geometric control of the vascular network 
The dermis vascularization have a fine architecture and there are works in literature 
which show that recapitulating vascular architecture in vitro can accelerate the 
formation of functional anastomoses in vivo [16][136]. For these reasons, we have 
used 2 different approaches in order to obtain a vascular network geometrically 
oriented.  
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In the first approach, we have achieved channeled biohybrids assembling µTPs 
around a capillary as stamp (Fig.9 A). HUVECs were seeded into the channel using 
a syringe pump. The obtained channel was surrounded by collagen as shown by the 
SEM images (Fig.9B/C) but it undergoes shrinkage during the culture period in fact 
the initial diameter of the cannel was of about 364µm (Outside diameter of the 
capillary used as stamp) whereas 10 days after endothelial cells seeding it was of 
about 150µm. HUVECs seeded into the channel form a capillary network into the 
channel spreading into the surrounding matrix (Fig 9D). 
 
  
 
 
Fig. 9 Channeled/vascularized dermis equivalent: A) Picture of the channeled biohybrid before capillary 
extraction; B) SEM image of the channeled biohybrid and magnification of the collagen matrix into the 
channel. Scale bar on the left 20µn, on the right 200nm; C) Immunofluorescence of the vascularized biohybrid, 
in red the HUVECs marked by UEAI and in gray the SHG collagen signal. The yellow arrows indicate 
vascular sprouts into the collagen matrix. Scale bar 100µm.  
 
The second approach consisted in the seeding of endothelial cells on a dermis 
equivalent in wire form kept in tension from the extremities. After 10 days of 
culture HUVECs developed a capillary network following the main direction of the 
wire (Fig.10). 
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Fig. 10 The capillary network follows the mail direction of the wire: Up on the left a picture of the 
biohybrid dermis equivalent bound at the ends. Up on the right and down images of the capillary network 
marked by UEAI in red, the SHG collagen signal in gray and the nuclei of all the cells marked in green by 
Sytox. Scale bar 100µm. 
4.3.3 Vascularized skin equivalent model 
Keratinocytes, seeded on the surface of the vascularized biohybrid dermis 
equivalent, proliferated, differentiated and stratified during the culture period. 
Histological and immunofluorescence analysis were performed 3 weeks after 
epithelial cells seeding. The histology showed the development of a keratinized 
epithelium on a complete basal lamina (Fig.11A). The epithelium expressed keratin 
14 in the basal layer and keratin 10 in the super basal layer. It was positive for p63, 
marker of the basal layer, and for involucrin and filaggrin, markers of the more 
external layer (Fig.11B). The 3d view showed the complete model featured by the 
presence of a stratified epithelium lying on the dermis compartment, which was 
strengthened by the endogenous ECM rich in collagen and in which the 
endothelium sprouted toward the epithelium (Fig.11C). 
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Fig. 11 Vascularized skin equivalent model: A) Hematoxylin eosin of a tissue section, the arrow indicates the 
basal lamina. Scale bar on the left 100µm, on the right 50µm. B) Immunofluorescence for K14 and Involucrin 
in red and for K10, p63, Filaggrin in green. In the images on the lower left the endothelial cells are marked in 
red by UEAI. Scale bar 50µm for all the images excluded the lower left which scale bar is 200µm. C) 3D View 
of the vascularized skin equivalent model with the epithelium marked in green by Sytox, the HUVECs in red 
by UEAI and the collagen matrix in gray by SHG. The red arrows indicate capillary like structures. 
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4.4 Discussion 
In this work, we have developed a vascularized dermis and a vascularized skin 
model strengthened by endogenous ECM produced by fibroblasts.  
We seeded HUVECs on the surface of a dermis equivalent biohybrid obtained by 
bottom up approach and rich in collagen [21] [113] which is one of the main 
component of the extracellular matrix responsible for tissue mechanical strength 
[87] [23]. This is a very important parameter considering that the gold standard 
skin substitutes should be slightly deformable, easily handled and able to withstand 
the shear forces in vivo [87] [130]. HUVECs, seeded on a surface of the sample, 
were able to deeply penetrate the collagen matrix for about 700µm (Fig.1), such as 
indicate by some endothelial cells migration assay in pro-angiogenic culture 
conditions [137] [138]. Endothelial cells formed a capillary-like network totally 
embedded into the stroma and evolving until 3 weeks of culture. These structures 
had a diameter of about 10µm, as most of the vessels in the human papillary dermis 
[91] and, from the orthogonal view (Fig.3C) and from the images of the structures 
at greater magnification, it is possible evaluate that they possess an inner lumen. 
CLS were growing up until 2 weeks and then regressing as demonstrated by the 
image analysis of the CLS volume fraction and n° of junctions/µm
3
. Node points 
were mostly triple, so among 3 structures (Fig.2). We consider that these 
parameters indicate a physiological evolution of the endothelial network in vitro. In 
fact normal angiogenesis refers to a naturally existing process of blood vessel 
growth and regression, and it occurs as an integral component of tissue repair and 
regeneration [139]. Capillary tube regression is a well-known response during 
wound repair, developing retina, and the menstrual cycle in the ovary and uterus in 
humans [140], and it occurs as natural secure mechanism [6]. Moreover, the fact 
that we found mostly triple junctions indicate a capillary-network expansion by 
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bifurcation as it occurs physiologically, whereas trifurcation is most frequent in 
pathological angiogenesis [41].  
The molecular analysis shows that the evolution of CLS in guided by VEGF and 
Angp-2. VEGF is the most well studied growth factors involved in ECs migration, 
mitogenesis, sprouting, and tube formation [141]. Angiopoietin-2 (Ang-2) is a 
biological antagonist of angiopoietin-1(Ang-1) and reduces vascular stability to 
block the stabilizing action of Ang-1. On the other hand, it was shown that in 
presence of VEGF, Ang-2 induces vascular sprouting and angiogenesis. Ang-2 is 
markedly expressed in organs that undergo vascular remodeling such as the ovaries 
and placenta [142]. In our experiment, the increasing overexpression of VEGF and 
Angp-2 leaded the expansion and remodeling of the vascular network until 2 
weeks. From 2 to 3 weeks the expression of VEGF became comparable to the 
control whereas Angp-2 still remained upregulated, so inducing vascular regression 
[140] (Fig.5). 
In 2 weeks capillaries gained a certain degree of structural maturity (Fig.6) being 
surrounded by laminin and collagen, which are key elements of the basal 
membrane around vessels, and by pericytes-like cells, positive for αSMA and 
mainly associated with blood vessel stabilization [143]. 
We speculate that the vascularized dermis equivalent model could be suitable for in 
vivo applications given its mechanical strength, easy handling and the presence of a 
physiological and mature endothelial network within the endogenous matrix. Our 
request for in vivo studies has been accepted by the Ethics Committee and next 
experiments will aim to evaluate the formation of functional anastomoses between 
the vascularized dermis equivalent and host vasculature after sub cutis graft into 
nu/nu athymic mice. 
To this end, we have evaluated the ability of endothelial cells to migrate from the 
vascularized dermis equivalent to a wound area achieved cutting biohybrids and 
placing them in close contact into the maturation chamber. Results (Fig.8) indicate 
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that most of the endothelial cells were able to invade the wound area, as typical of 
the granulation tissue [140]. We argue that this feature, besides indicating the tissue 
ability to recapitulate a physiological event, could increase the chance to form 
functional anastomosis in the wound area between host tissue and implant after in 
vivo graft. 
Moreover, we have evaluated that it is possible obtain a geometric control of the 
vascular network by seeding endothelial cells on a dermis equivalent model with 
specific form and features. In our experiment, after HUVECs injection into a 
channeled biohybrid, CLS preferentially developed into the channel and then 
sprouted into the surrounding matrix (Fig.9). Endothelial cells, seeded on a wire 
shaped dermis equivalent, followed the main geometric direction of the biohybrid 
(Fig.10). This is very interesting because in vivo human dermis vascular network 
has a fine architecture with 2 main parallel plexuses connected by capillaries and 
trying to reproduce this vessel organization in vitro could improve graft outcomes. 
In fact it was demonstrated that multicellular architecture in tissue is very important 
to guarantee tissue integration via the formation of functional anastomosis between 
the vascular network of the implant and that of the host having the same 
preferential direction[16]. 
Keratinocytes, seeded on the opposite surface of the vascularized dermis equivalent 
compared to endothelial cells, developed a stratified, keratinized and differentiated 
epithelium in 3 weeks of culture. Cells of the germinative layer expressed p63 
which is important to initiate epithelial stratification and to maintain the 
proliferative potential of basal keratinocytes in mature epidermis [144] [22]. The 
basal layer of the epithelium was positive for K14, a fundamental keratin of all 
keratinocytes in stratified epithelia, whose expression is correlated with the mitotic 
activity and degree of potency of basal cells. Post-mitotic keratinizing cells in the 
supra basal layers of the epidermis expressed K10, a keratin which apparently 
prevents further cell divisions. The terminal differentiation of epidermis was 
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demonstrated by the expression involucrin and filaggrin in the stratum corneum 
[145] [22]. The presence of a mature epithelium could improve tissue functions 
acting as barrier and cross-talking with the dermis layer [130] [22]. From the 3D 
reconstruction in Fig.11C it is possible to see the complete vascularized skin model 
with a stratified epithelium lying on the dermis compartment strengthened by the 
endogenous ECM rich in collagen, in which the endothelium sprouts toward the 
epithelium. Capillaries do not enter in direct contact with epithelial cells as it 
happens in the in vivo condition in which they exchange substances by diffusion 
within the connective tissue [82]. 
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4.5 Conclusions and Future Perspectives 
This work focus on the development of a vascularized dermis/skin equivalent 
model for clinical applications. Despite the improvements occurred in the last year 
in the study of vascularized engineered models, none of the dermis/skin substitutes 
used in the clinic is actually pre-vascularized. The presence of a capillary network 
has a central role in determining the success of full-thickness graft. 
We show that endothelial cells, seeded on a surface of a biohybrid dermis 
equivalent, are able to develop a capillary like network branching into the 
endogenous ECM, produced by fibroblasts and rich in collagen. These structures 
physiologically evolve and gain structural maturity in 2 weeks.  
Endothelial cells migrate in the wound area during in vitro assay and can develop 
structures geometrically oriented under specific culture conditions. Thus, 
encouraging the chance to form functional anastomosis after in vivo graft and so 
the feeding of the entire tissue. 
Next experiments will aim to in vivo trials but we speculate that the vascularized 
dermis/skin equivalent model could also be exploited as research platform and for 
drug screening.  
The model could be suitable for fundamental research since it recapitulates both 
vascular progression and regression, phenomena characteristics of adult 
physiological angiogenesis and wound healing. 
Moreover, the vascularized dermis/skin model could be used for the screening of 
molecules or principles acting via topical administration on the vascular network, 
such as vaso-constriction/dilatator, anti-inflammatory or pro- and antiangiogenic 
drugs. 
In view of this kind of application it might be interesting evaluate other quantitative 
parameters related to vascular tissue function such as vasoconstriction or dilatation 
in response to thermal variations. 
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Since most of these drugs are systemically administrated, it could be very attractive 
find a way to perfuse CLS in vitro. The tissue could be integrated into a 
microfluidic device in order to promote the formation of anastomoses between the 
vascular network and channels acting as accessible vascular pedicles. Thanks to in 
vitro perfusion it would be possible characterize other fundamental vascular 
features such as permeability, leukocytes adhesion and vascular response to 
inflammatory stimuli. 
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